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in August 2009 
Human papillomavirus (HPV) infection is a prerequisite for the development of 
cervical cancer. There are approximately 13-15 types of high-risk (HR) HPV that are 
associated with cervical cancers. HPV58 is an HR-HPV type which accounts for 
more than 3% of cervical cancers worldwide, and with a higher prevalence observed 
in certain parts of the world especially East Asia. This study examined the sequence 
variation, phylogeny, and evolution of HPV58 isolates collected worldwide. 
A total of 571 HPV58-positive samples, including 521 cervical scrapes and 
biopsy specimens, and 50 penile scrapes were collected from 15 cities/countries over 
five continents. The DNA sequences of E2, E4, E5, E6, E7, LI, and LCR were 
obtained from over 400 HPV58 isolates. 
Phylogenetic analyses revealed that the LI encoding region provided the best 
information for lineage classification, from which four lineages (A-D) of HPV58 can 
be defined. A short gene fragment of 188 base pairs at position 6641-6828 comprised 
the most informative sequence signature for the differentiation of these four lineages. 
A geographical predilection was observed, with lineage A more commonly detected 
in Europe and in America, lineage D in Africa, and lineages B and C in Asia. 
By using entropy values to determine the variability of each gene, the E6 gene 
V 
was found to be the most conserved gene region (average entropy value = 0.0043) 
within the HPV58 genome, followed by E2 (0.0068), LI (0.0110), E4 (0.0116), E7 
(0.0173), and E5 (0.0174); while LCR (0.0292) was the most variable. The 
non-synonymous to synonymous substitution rate ratios (dN/dS) of five of the six 
open reading frames were significantly less than one, indicating that these genes, and 
the HPV58 genome as a whole, were under a purifying selection pressure. Only the 
E6 gene had a dN/dS value larger than one. 
The effectiveness in the detection of HPV58 using five sets of commonly used 
primers targeting the LI region were predicted by directly comparing the sequences 
of the primers and the gene sequence of HPV58 isolates in this study. Two 
mismatched nucleotide positions were found in PGMY09/11, one in MY09/11, seven 
in GP5+/6+, four in SPF, and five in LIF/LIR primer systems. These mismatches 
might jeopardize the sensitivity of PGR assays, and lead to an underestimation on the 
prevalence, and hence the importance, of HPV58. 
This study has provided a comprehensive set of sequence data for HPV58 
isolates collected around the world. This information is instrumental for designing 
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HKY+I Hasegawa-Kishino-Yano model with an invariable site assumption 
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ORF open reading frame 
ori origin of replication 
p53 tumour protein 53 
PAUP* Phylogenetic Analysis Using Parsimony* 
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TVM+I transversional substitution model with an invariable site assumption 
TVM+I+G transversional substitution model with a gamma distribution of rate of 
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TW Taiwan 
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USA United States of America 
XI 
URR upstream regulatory region 
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VLP virus-like particle 
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Chapter One - Literature Review 
Chapter One 一 Literature Review 
1.1 History of Knowledge on Human Papillomavirus 
Warts found on human skin were observed long ago and has been described in 
classical medical books both in the East and the West since ancient times. The 
transmission property of warts has also been realised for a long time. However it 
took more than another two thousand years for the understanding on the viral 
aetiology of warts [Strauss et al 1949，Dun et al 1968]. 
Although cervical cancer has been described by physicians for hundreds of years, 
the relationship between cervical cancer and human papillomavirus (HPV) was not 
confirmed until 1974 by Harald zur Hausen [zur Hausen et al 1974]，whereby he 
successfully identified by nucleic acid hybridisation methods the presence of HPV 
DNA in cervical cancer biopsy samples. Subsequently his research team successfully 
cloned the genome of the two most prevalent HPV types in cervical cancer, and these 
genomes had been found in a significant proportion of cases of cervical cancer 
worldwide [Durst et al 1983，Boshart et al 1984]. 
By the 1980s, detection methods for HPV were continuously improved which 
led to the identification of more HPV types [Brigati et al 1983，McDougall et al 
1986]. The relationship between HPV oncoproteins and the development of cervical 
carcinoma was also evidenced by different observations and in vitro experiments 
[Crook et al 1988，Phelps et al 1988，Storey et al 1988，Bedell et al 1989]. 
By the 1990s, a large amount of epidemiological information on the association 
between cervical lesions and HPV was generated [Schneider and Koutsky 1992, 
Vittorio et al 1995]. Diagnostic assays for clinical HPV detection were also available 
and improved for the detection of HPV infections [Snijders et al 1990, Rando 1990， 
Farthing et al 1994]. 
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By mid-2000, two prophylactic vaccines, namely Cervarix® and Gardasil®, 
against the two most common high-risk HPV types, HPV16 and HPV18, and the two 
most common low-risk types, HPV6 and HPV 11 were launched for the prevention of 
HPV infections and the subsequent development of cervical cancer and genital warts. 
It is now widely believed that a good coverage of these vaccines will effectively 
lower the incidence of HPV-related carcinomas. 
After about 30 years of its discovery, in 2008, Harald zur Hausen was awarded 
the Nobel Prize in Physiology or Medicine for his pioneered work on the causal 
association between HPV and cervical cancer. This Nobel Prize also landmarked the 
important status of HPV in the world today and publicised the awareness of this virus 
and its potential burden to both human health and to the society. 
1.2 Virology of Human Papillomavirus 
1.2.1 Taxonomic Classification of Human Papillomavirus 
Since HPV does not efficiently induce an antibody response in human, the virus 
is classified by a genetic approach rather than by serologic one [Coggin and zur 
Hausen 1979, van den Hende et al 2008]. HPV was originally classified by its 
genomic properties using restriction enzymes producing different patterns in 
restriction digests [Coggin and zur Hausen 1979]. Up until 1994, the classification 
was changed to be based on the genomic sequence of E6, E7, and LI gene. The 
definition of a new HPV type was defined when these three genes have more than 
10% difference with all the other defined types [de Villiers 1994]. Ten years later, the 
most updated classification method was announced, whereby it was based solely on 
the whole sequence of the LI gene [de Villiers et al 2004]. 
There are more than 120 HPV genotypes characterised at present. If the 
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sequence of the LI ORF of an HPV genome contains over 90% homology with the 
LI sequence of any defined prototype, that HPV will be reported as that genotype. 
But if the LI sequence contains less that 90% homology with any defined HPV 
prototype, the HPV genome will be regarded as a new genotype. The type number is 
named by the order of its discovery [Weiss 2008]. 
HPV types with close phylogenetic relationship and biological properties are 
grouped into species, and species are grouped into genera [de Villiers et al 2004]. 
Within the same species, the types share between 71% to 89% identity in nucleotide 
sequences within the LI gene. For example, HPV 16, the most common HPV 
genotype in cervical cancer, belongs to species 9 of genus alpha, or species a9. This 
species also includes six other HPV types, namely HPV31, HPV33, HPV35, HPV52, 
HPV58, and HPV67. All of the members are found to be associated with cervical 
carcinoma and have been shown to have similar biological properties [Munoz et al 
2003]. 
1.2.2 Morphology of Human Papillomavirus 
An intact HPV virion is formed by 72 pentamers of LI proteins and 12 
monomers of L2 proteins [Buck et al 2008]. The LI proteins arrange as a T=7 
icosahedral lattice with a diameter of about 45 to 60 nm, depending on the pH and 
ionic concentration of the environment [Baker et al 1991, Mukherjee et al 2008]. 
1.2.3 The Viral Genome 
The HPV genome is a circular double-stranded DNA molecule of about 8,000 
base pairs (bps) in length. It comprises of approximately eight open reading frames 
(ORFs) that are transcribed as polycistronic mRNAs from a single DNA strand, 
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coding for eight viral proteins, and one non-coding region called the upstream 
regulatory region (URR) or the long control region (LCR), which contains the cis 
elements for the genome replication and the transcription of viral genes. The overall 
organisation of an HPV genome using HPV16, the most prevalent HPV type in 
cervical cancers, as an example is illustrated in Figure 1.1. 
Figure 1.1 Genome Organisation of HPV16. 
Oh 
LCR 
Genome size: 7904 bp 
Ori\ Origin of replication 
The long control region (LCR) is the longest non-coding region in an HPV 
genome. It varies from about 700 to 900 bps in length among different HPV types. It 
contains binding sites for transcription and regulatory factors for initiation and 
regulation in the expression of viral genes. It is the most variable region in the HPV 
genome [Stewart et al 1996，Calleja-Macies et al 2005]. The size and variability of 
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the LCR have attracted several research teams to make use of the sequence to study 
the phylogeny of HPV [Heinzel et al 1995, Ho et al 1991，Ho et al 1993, Ong et al 
1993]. 
The variability of a gene among a set of sequences can be measured by the 
entropy value, which can provide an objective and quantitative index for the 
calculation of the variability. Entropy is a method to measure the variability of a 
position within a gene region [Thomas 1999]. Although the entropy approach is more 
commonly used in measuring the variability of residues in proteins or peptides [Chen 
et al 2006，Troeash et al 2006], the principle can also be applied to assess the 
variability of a gene region. Compared with the variability indicated by direct 
counting of variable nucleotide position per length of gene region, the entropy 
approach gives a more reasonable measure of the randomness or uncertainty because 
it takes into account the four possible nucleotides of every position of each sequence 
in the calculation. 
1.2.4 The Viral Gene Products 
Most of the known HPV genomes code for eight viral proteins, which are 
divided into early (E) and late (L) proteins depending on their time of expression in 
the HPV life cycle [Doorbar 2006]. Early in the infection, E proteins are expressed 
from the early promoter before the reproductive replication of HPV, while the L 
proteins are expressed from the late promoter for the formation of new virions during 
the vegetative replication stage. 
1.2.4.1 El and E2 Proteins 
Both of the HPV El and E2 proteins carry important roles in the replication of 
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the viral genome. The El gene codes for an ATP-dependent helicase, which unwinds 
the viral DNA and recruits the replication machinery for genome replication [Hebner 
and Laimins 2006]. 
The E2 protein is also essential for viral replication. It forms a dimer and 
facilitates genome replication by linking with the El protein and the LCR of the 
DNA template to be replicated [McBride et al 1991]. In addition, the E2 protein is 
also a regulator of viral gene expression. Low levels of E2 protein promote the 
transcription of the E6 and E7 genes while high levels repress it [McBride et al 1991， 
Jeon et al 1995]. 
The El and E2 genes are large and stable genes, and have been used in some 
phylogenetic studies among HPV species and genera [Bravo and Alonso 2007]. 
1.2.4.2 E4 Protein 
The E4 protein is also known as the E1^E4, since the first five residues, 
including the starting methionine of the protein are encoded by the El open reading 
frame. Although the exact function of the E4 protein is not fully understood, it is 
known that the protein is actively expressed during the productive cycle to modify 
the infected cell for viral genome replication [Roberts et al 2008]. Loss of the E4 
protein results in the loss of a wide range of viral functions, including failure in the 
activation of cell cycle checkpoints, the production of new virions, and in the 
induction of keratinocyte formation [Roberts et al 1994, Peh et al 2004, Wilson et al 
2005, Roberts et al 2008]. It has also been discovered that the accumulation of 
N-terminally truncated E4 protein can give rise to the formation of amyloid fibres in 
the cytoplasm, leading to the subsequent disruption of cellular integrity and a range 
of cellular functions [Mcintosh et al 2008]. 
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1.2.4.3 E5，E6, E7 Proteins 
E5, E6 and E7 are the three oncogenes of HPV. The E5 ORF codes for a 
hydrophobic protein, whose function can alter the structure and function of receptors 
for the epidermal growth factor (EGF) and the platelet-derived growth factor (PDGF)， 
hence preventing the normal growth inhibition mechanisms and in the stimulation of 
abnormal cell proliferation [Bouvard et al 1994，Straight et al 1993]. It can also 
enhance the transforming activity of the E6 and E7 proteins of high-risk HPV types 
[Bouvard et al 1994] and the induction of cell fusion and the subsequent 
chromosomal instability [Hu et al 2009]. 
The E6 protein interacts with a number of cellular proteins to prevent apoptosis 
of the infected cells. It has the ability to increase telomerase activity and cell 
proliferation, and to disrupt the cytoskeleton of the infected cells [Scheurer et al 
2005]. The most important pathway of E6 is that it can bind to the E6-associated 
protein (E6-AP), a cellular ubiquitin ligase, to form a complex [Huibregtse et al 
1993]. This complex in turn can bind to the tumour suppressor protein p53 to 
promote an ubiquitin-mediated degradation of p53, resulting in the inhibition of 
apoptosis and the continuation of DNA synthesis mechanisms [Scheffner et al 1990]. 
The E6 protein can also re-activate telomerase hTERT [Veldman et al 2001], which is 
inactivated in most normal somatic cells. The re-activated hTERT then extends the 
life span of the infected cells and thus facilitating in cell transformation. 
The E7 protein disrupts cell cycle regulation and hence leads to the 
transformation of the infected cells [Scheurer et al 2005]. One of the most 
well-known functions of E7 protein is its binding with tumour suppressor proteins, 
including the retinoblastoma protein (pRB) family. The E7 protein reduces the pRB 
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half-life and thereby the function of monitoring cell cycle is inhibited [Phelps et al 
1992, McLaughlin-Drubin and Miinger 2009]. Moreover, the E7 protein can also 
disrupt the regulation of normal cell cycle by upregulating cyclin dependent kinases 
(cdks) and by reducing the level of inhibitors of these kinases [Zerfass et al 1995]. 
The E6 and E7 proteins have also been reported to contain epitopes for cellular 
immunity [van den Hende et al 2008] and hence could be targets of therapeutic 
vaccines against HPV infections. 
1.2.4.4 LI and L2 Proteins 
LI and L2 are two capsid proteins that comprise the capsid coat of an HPV 
virion. 
The LI protein is also called the major capsid protein. An HPV virion contains 
six times as many LI proteins to one L2 protein and thus L2 is also known as the 
minor capsid protein. The LI protein itself can self-assemble into a virus-like-particle 
under suitable conditions [Mukherjee et al 2008]. The LI protein is currently 
believed to play a major role in binding to human cells. It has been found to have a 
high affinity to a group of receptors called heparan sulphate proteoglycans (HSPGs), 
including syndecan-1, which is predominately found in human epithelial tissue [Sapp 
and Day 2009]. 
The function of the L2 protein is to facilitate the assembly of an HPV virion and 
to induce conformation changes of the virion for cell entry [Buck et al 2008]. The L2 
protein is cleaved by furin, an enzyme that is commonly found on the surface and in 
the Golgi apparatus of human cells. The cleaved L2 protein contributes to cell-virus 
interaction for subcellular trafficking and uncoating of the viral genome [Buck et al 
2008, Sapp and Day 2009]. 
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These two capsid proteins have the highest medical value among all HPV viral 
proteins because they are the most immunogenic gene products of HPV for inducing 
the production of protective antibodies against HPV. The currently available 
prophylatic vaccines are based on HPV virus-like-particles, which are assembled by 
only the LI proteins [Kimbauer et al 1992]. On the other hand, the L2 protein is now 
one of the potential targets for the HPV vaccine of the next generation, since the 
immune response triggered by the L2 protein shows a higher degree of 
cross-neutralisation among different HPV types [Roden et al 2000, Berzofsky et al 
2001], owing to the conservative cleavage sites recognized by furin [Sapp and Day 
2009]. 
The LI gene is also the most important region for diagnostic use. The current 
classification of HPV types is based on the homology on the LI gene [de Villiers et 
al 2004]. Commonly used primers for the detection of HPV in clinical specimens 
also flanks a region of the LI gene [Kleter et al 1998，Ting and Manos 1990, Gravitt 
et al 2000, Snijder et al 2005, Jeney et al 2007]. 
1.3 Evolution of Human Papillomavirus 
The use of DNA sequences to study molecular phylogeny dates back 40 years 
ago [Fitch et al 1967, Fitch and Margoliash 1967]. Since then, phylogenetic studies 
have been performed on a wide range of organisms, and at the same time, methods 
for phylogenetic analyses are continuing to improve. 
The basis of phylogenetics is that the evolution of every organism is governed 
by a molecular clock [Fitch and Langley 1976]. Random changes in the genomic 
sequence of a particular group of organisms accumulate at a rate that can be 
expressed as a function of time. Viruses, possessing a genomic content, also follow 
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the rules of a molecular clock, although the rate of evolution varies greatly among 
different viruses [Duffy et al 2008]. 
Currently there are a few approaches that are available for analysing the 
phylogenetic relationship among input sequences through the use of computer 
programs. PAUP* 4.0 is one of the most popular one [Holder and Lewis 2003]. Out 
of the predefined 56 models for nucleotide substitution matrix, the best model to 
describe the pattern of evolution of the input sequences is first selected with the 
program. Then a thorough search for the maximum-likelihood (ML) tree is made 
based on a neighbour-joining (NJ) starting tree. The best ML tree is the tree with the 
highest likelihood under the selected model and it accurately illustrates the 
relationship among the input sequences. Another newer approach is the Bayesian 
approach, which constructs the best phylogenetic tree by maximising the posterior 
probability of the tree with the Markov Chain Monte Carlo algorithm. The Bayesian 
approach is parameter-rich and it can estimate the shape of the phylogenetic tree and 
the uncertainty of branches at the same time. The construction of a phylogenetic tree 
by this approach is generally faster than the traditional approach. These advances on 
phylogenetic methods have provided convenient tools for the analysis of the 
evolution of HPV. 
Human viruses are categorised into different groups mainly based on the type 
and organisation of viral genome [Baltimore 1971]. Papillomaviruses, with 
double-stranded DNA genomes, are monophyletic in virus taxonomy, and 
polyomaviruses are its close neighbours. 
On the other hand, papillomaviruses that infect humans do not constitute a 
monophyletic group, since there are some types infecting humans and some infecting 
other animals under some major genera of papillomavirus, including genus alpha and 
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beta [Hughes and Hughes 2005]. Although DNA viruses tend to be more 
host-specific than RNA viruses, papillomavirus, as a whole, infects a range of species 
in mammals and birds [Fields et al 2007]. This shows that papillomavirus has been 
co-evolving with their hosts for a very long period of time and is now well adapted to 
their own host-specificity [Gottschling et al 2007]. 
When compared with RNA viruses, DNA viruses, including HPV, tend to have a 
slower mutation rate and thus have a greater potential in making a clearer 
evolutionary relationship by tracking back its evolution. 
1.3.1 Rates of Evolution 
HPV is a DNA virus without any RNA stages in its replication cycle and 
therefore has a very slow mutation rate, although the molecular clock is by no means 
constant. As the replication of the papillomavirus utilises the proofreading DNA 
polymerase in host cells, the mutation rate of papillomaviruses has been estimated to 
be as slow as one mutation in the LCR per about 12,000 years [Ho et al 1993], or 
approximately 1.95x10'^ substitution per site per year [Rector et al 2007, Chen et al 
2009]. 
Recombination is also a major source of diversity in the evolution of many 
viruses. However in HPV, the recombination event is extremely rare in current 
observations and the current evidence of recombination is still confined to 
bioinformatic approaches without concrete clinical or in vitro evidence [de Villiers et 
al 2004, Varsani et al 2006, Carvajal-Rodriguez 2008]. 
1.3.2 Co-evolution Between Human Papillomavirus and Human 
Same as most, if not all, of other viruses, HPV evolves for maximizing its 
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reproductive fitness in their host. A virus and its host ultimately reach an equilibrium 
state at which neither the virus nor the host manages to kill or eliminate each other in 
both individual and at the population level, maintaining an effective reproduction of 
both the virus and host. 
For an human virus including HPV, the sophisticated human immune system is 
a great challenge for establishing an effective and long-lasting infection in human 
body. After the long mutual adaptation for countless number of generations, HPV has 
handled this problem very well. HPV does this by infecting mostly less immunogenic 
areas without causing cell lysis or viremia，and by releasing new virions only on the 
superficial layers of epithelial cells [Frazer 2009], thus making antigen presentation 
and the adaptive arm of the immune system less effective, leaving only about one 
half of the natural infections to induce an HPV specific antibody response [Carter et 
al 2000]. In addition, most of the transient and persistent HPV infections are neither 
particularly virulent nor life-threatening. In fact over 80% of HPV infections show 
no symptoms before their clearance [Snijders et al 2006]. This preserves the life and 
health of the host for a better chance of transmission. 
It is widely believed that papillomaviruses have interacted and co-evolved with 
humanoids and other primates for millions of years [Chen et al 2009], much longer 
than the emergence of Homo sapiens modem human since not more than 500 
thousand years ago according to phylogenetic studies carried out on human 
mitochondrial DNA [Stoneking and Soodyall 1996] and Y chromosome [Mitchell 
and Hammer 1996]. Host-linked evolution is regarded as a main driving force for the 
evolution and diversification of HPV. In at least HPV 16 [Ho et al 1991，Chan et al 
1992, Ho et al 1993] and HPV 18 [Ong et al 1993]，the two most prevalent HPV 
types in cervical cancer, a relationship between HPV variants and geographical 
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location has been reported. 
On the other hand, studies on the evolution of HPV can also provide 
information on human evolution. Scientists have proposed that DNA viruses 
including HPV are useful markers to study the diversification history of human 
populations. 
1.4 Human Papillomavirus Infection and Disease 
HPV is mainly transmitted horizontally by sexual contacts or skin contacts 
[Fairley et al 1995]. HPV infection is the most common sexually transmitted disease. 
More than half of the people are infected by HPV in the first two years of sexual 
activity [Koutsky et al 1997] and about 80% of adults with sexual experience have 
been infected by HPV during their lives [Baseman and Koutsky 2005, Lowy and 
Schiller 2006]. Over eighty percent of HPV infections are transient and are cleared 
within 6 months to two years leaving no symptoms [Schiffman et al 2007]. 
1.4.1 Human Papillomavirus and Cervical Cancer 
1.4.1.1 Disease Burden of Cervical Cancer 
Among all HPV-related diseases, cervical cancer causes the largest threat to 
human health and cost to the society. There are about 500,000 incident cases of 
cervical cancer and over 270,000 deaths every year worldwide [Castellsague et al 
2007], with an even higher prevalence in developing countries [Castellsague et al 
2007]. The progression to cervical carcinoma from an initial HPV infection usually 
takes more than a decade [Schiffman and Kjaer 2003], leaving a long period of 
precancerous cervical lesions, that allows an effective screening system to intervene 
to prevent the development of cancer if carried out effectively. 
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1.4.1.2 Epidemiology of Cervical Cancer 
Persistent infection by HPV is believed to be necessary for the carcinogenicity, 
but carcinogenicity is not a pure function of persistence [Schiffman et al 2005], since 
the host factors and evolutionary factors of HPV are also needed to be taken into 
account. 
Different HPV types contribute to different risks for carcinogenicity and, 
therefore，HPV types are divided into high-risk and low-risk types [Munoz et al 
2003]. There are approximately 15 mucosal HPV types classified as high-risk types 
as they are more strongly associated with the development of cervical cancer [Munoz 
et al 2003]. 
HPV 16 and HPV 18 are the two dominant HPV types causing carcinoma in the 
cervix, with a prevalence of 54.4% and 15.9% respectively in cervical cancer cases 
worldwide [Castellsague et al 2007]. These two HPV types can cause as much as 
80% of cervical cancer, thus are the target of the currently available HPV 
prophylactic vaccines. Other common HPV types include HPV33, HPV45, HPV31, 
HPV58, HPV52 and HPV35 in the order of prevalence, ranging from 4.3% to 1.7% 
[Castellsague et al 2007]. 
1.4.1.3 Distribution of HPV types in Cervical Precancerous Lesions 
Similar to the distribution pattern of cervical cancer, all the most prevalent HPV 
types detected in high-grade lesions are high-risk types. The most prevalent type 
worldwide is HPV 16, which accounts for 45.4% of diagnosed cases, followed by 
HPV31 (8.70/0)，HPV33 (7.3%), HPV58 (7.0%), HPV 18 (6.9%), HPV52 (5.1%), 
HPV35 (3.8%), and HPV51 (3.6%) [Castellsague et al 2007]. 
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The HPV type distribution pattern in low-grade lesions is more evenly 
distributed, with HPV 16 still being the most commonly detected type. It has been 
detected in 20.3% of cases, followed by HPV31 (8.3%), HPV51 (8.3%), HPV53 
(7.8%), HPV56 (7.40/0)，HPV52 (6.9%), HPV66 (6.6%), and HPV 58 (6.4%) 
[Castellsague et al 2007]. 
1.4.2 Human Papillomavirus and Non-cervical Diseases 
Apart from cervical cancer, HPV also causes carcinomas at a number of other 
sites of the human body including anus, vagina, penis, mouth and throat, contributing 
to over 50,000 cases per year worldwide [Parkin and Bray 2006]. 
HPV is well known to be the etiological agent for warts, or benign cutaneous 
tumours, on human skin [Bernard 2005]. Genital warts, or condyloma acuminata, are 
benign tumours growing in the anogenital area. Around 90% of genital warts are 
caused by HPV6 or/and HPV 11 [Bosch et al 1995, Wiley et al 2002]. Oral warts are 
found to contain the following common HPV types: HPVl, HPV2, HPV4，HPV7 and 
HPV57 [Padayachee 1994]. Flat warts on hands and feet are also caused by HPV. 
1.5 Human Papillomavirus Type 58 
1.5.1 Biology of Human Papillomavirus Type 58 
HPV58 was first described by Matsukura's research team in 1990. It was 
isolated from a Japanese woman suffering from invasive cervical carcinoma. The 
whole genome of HPV58 was cloned in the following year, where the prototype 
sequence, containing 7,824 nucleotides with a GC content of 37.9% was defined 
[Kirii et al 1991]. This HPV type has a similar genome organisation to other common 
types. It has seven ORFs in genomic order, E6, E7, El , E2, E4, E5, L2 and LI 
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proteins. 
HPV58 belongs to species 9 of the alpha-papillomavirus genus, which contains 
seven high-risk HPV types [de Villiers et al 2004], altogether accounting for 
approximately 70% of cervical cancer cases worldwide [Castellsague et al 2007]. 
The odds ratio of HPV58 infection for cervical cancer development is 114.8 
[Munoz et al 2003], which is significantly over 45.0, the arbitrary cut-off value of 
being classified as a high-risk type. 
1.5.2 Epidemiology of Human Papillomavirus Type 58 Infections 
In a worldwide prospective, HPV58 is the sixth most common HPV type in the 
development of cervical cancer, the fourth in high-grade cervical precancerous 
lesions and the eighth in low-grade lesions [Castellsague et al 2007]. It is detected in 
3.30/0，7.0%, and 6.4% of cervical cancer, high-grade, and low-grade lesions 
worldwide, respectively [Castellsague et al 2007]. 
In certain regions in the world, the impact of HPV58 infection is more 
significant. In the Asia continent, HPV58 accounts for 5.6% of cervical cancers, 
12.2% of high-grade lesions, and 10.2% of low-grade lesions. In these three grades 
of lesions, HPV58 ranks the third, the second, and the second among all HPV types 
respectively [Castellsague et al 2007]. In Eastern Asia the prevalence of HPV58 in 
cervical cancer is as high as 6.5% [Castellsague et al 2007]. 
In particular, HPV58 is the second or third most common HPV type found in 
cervical cancer in a number of studies carried out on the Chinese population [Lai et 
al 1999, Liaw et al 1995, Huang et al 1997，Lin et al 1998，Chan et al 1999, Dai et al 
2007, Qiu et al 2007]. It is the responsibility of us to make a more in-depth study on 
this genotype for the sake of the health of people in this region. 
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Chapter Two - Background and Objectives of Study 
2.1 Background of study 
2.1.1 The Need for Research on HPV58 
At the present moment, two HPV vaccines are commercially available in the 
market for the prophylactic prevention of HPV infection. These two vaccines have 
the ability to prevent around 70% of cervical cancers. However, these two vaccines 
do not cover all the high-risk HPV types that are found in cervical cancers. Therefore 
it would be more ideal to cover more high-risk HPV types in the second generation 
vaccine to aim for a better and higher protection. 
HPV58 is one of the most prevalent high-risk HPV types in certain regions of 
the world, such as Western Africa, Central America, and Eastern Asia. Due to its 
higher prevalent rate in our locality, we have taken this opportunity to use this 
advantage to explore the knowledge on this HPV type and to provide more data for 
further research work. 
2.1.2 Intratypic Classification System for HPV 
By definition, HPV isolates under the same type are allowed to have a 
maximum of 10% difference in the LI gene when compared with the prototype. A 
difference between 2% and 10% in the LI gene is defined as a subtype, while those 
with a difference less than 2% are classified as variants. Despite these small 
variations, variants especially of the high-risk type may have the potential to alter the 
biological properties and thus the disease outcome [Sichero et al 2006, Pista et al 
2007]. 
HPV 16 is the most widely studied HPV type since it is the most common HPV 
type detected in carcinoma cases in all regions in the world. Many phylogenetic 
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studies focusing on HPV16 have been conducted since the 1990's [Ho et al 1991, 
Chan et al 1992, Ho et al 1993]. From these studies, it has been found that variants of 
HPV16 have co-evolved with different human ethic groups and is now clustered into 
five distinct lineages based on a distinguished set of markers in the viral genome 
sequence. 
Since then, studies on the properties of different HPV16 lineages have been 
carried out and different prevalence, persistence of infection, and carcinogenicity has 
been found to occur in different lineages [Pillai et al 2002, Sichero et al 2006, Pista et 
al 2007, Tornesello et al 2008]. • 
The finding with the highest clinical importance is that there is a linkage 
between lineage of HPV16 and the risk of development of cervical cancer. The 
European lineage of HPV16 was found to be less carcinogenic than non-European 
lineages [Sichero et al 2006]. It is reasonable to predict that there are similar linkages 
between lineages and pathogenic risks in other high-risk HPV types. Therefore, 
building up a lineage definition for HPV58 would facilitate subsequent clinical study 
on the risk association of the virus. 
Information acquired from intratypic variation will most likely to bring more 
scientific impact and insight into the current knowledge on HPV. Data from studies 
on the intratypic genomic diversity for at least 20 different HPV genotypes are 
available [Deau et al 1993, Heinzel et al 1995, Stewart et al 1996, Chan et al 1997， 
Calleja-Macies et al 2004, Calleja-Macies et al 2005, Prado et al 2005]. However, the 
sample sizes, study populations, and the gene regions analysed varied among these 
studies and hence no consensus conclusions can be drawn. This study, on the 
contrary will focus on only one HPV genotype, and with the coverage of seven 
representative gene regions. This will provide a large database of intratypic 
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variations for HPV58. 
2.2 Implication and Impact of Study 
This study has generated a worldwide collection of sequences for HPV58 and 
has created a database for the analysis of intratypic diversity of this DNA virus. This 
information has provided a high value not only in scientific research on the virus but 
also in the design of therapeutic strategies and preventive vaccines. 
2.2.1 Implication on HPV Virology 
HPV contains a small DNA genome with a slow and consistent rate of mutation 
and with very rare recombination or horizontal gene transfer. HPV has co-evolved 
with its hosts for a very long period of time and is well adapted in its own biological 
niche. These properties make HPV to be a good model for the study of evolution o f � 
DNA viruses [Ong et al 1993]. Therefore the data collected from the sequence 
variation of HVP58 will generate a valuable tool for studies on the intratypic 
evolution of an oncogenic HPV type in addition to the well-studied HPV 16 and 
HPV 18. Intertype evolutionary model could then be the next step of research plan by 
comparing the findings of HPV58 evolution with the other two most common 
high-risk HPV types, HPV 16 and 18. 
2.2.2 HPV58 Classification 
Defining a lineage system for HPV58 will facilitate the understanding of this 
HPV type, and hopefully information obtained from different biological properties 
relating to different lineages can provide more answers to the epidemiology and risk 
association of this HPV type. 
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A good lineage system should be precise in the definition of a lineage and be 
built on representative and concrete evidence. It should also be easy to follow so that 
variants of HPV58 detected can be assigned and implemented in a lineage system at 
a low cost. The classification of HPV58 variants should facilitate the scientific 
studies on the virology and epidemiology of HPV58. This may increase the 
predictive value of HPV testing. 
2.2.3 Improvement on in the Detection of HPV58 
Furthermore, commonly used primers such as PGMY09/11, MY09/11, GP5+/6+, 
SPF, and LIF/LIR designed for the detection of HPV and identification of HPV 
genotype in clinical samples are frequently used [Kleter et al 1998，Ting and Manos 
1990, Gravitt et al 2000, Snijder et al 2005, Jeney et al 2007]. These primer sets 
target a fragment in the LI gene, which is the most conserved gene region among the 
different HPV types. However，since the binding sites of these primers vary, it is 
reasonable to argue whether the efficiencies are the same among different variants of 
HPV58. Therefore, the effectiveness of the different primer sets in terms of coverage 
on different variants was analysed. 
2.2.4 Implication on Vaccine Development 
The database on HPV58 will provide a useful set of information for the 
development of vaccines against this HPV type. The second generation of HPV 
vaccine will be very likely to include more common high-risk HPV types, including 
HPV58, to broaden its protection against cervical cancer. Only one or very few 
predominant variants of each HPV type would be included in the vaccine. The 
database on the LI sequences of HPV58 will provide information on a world-wide 
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basis on the variability in the sequence of circulating HPV58 variants, and will help 
in the design of the vaccine. 
Thorough knowledge on the genome of HPV58, especially the LI gene, would 
provide information for scientists to further investigate any modifications, such as 
epitope enhancement, on the amino acid sequence to enhance the effect of future 
VLP vaccines. Engineering of the amino acid sequences could improve the 
immunogenicity, solubility, stability, or other properties of the VLP vaccines. The 
theory can also be applied to therapeutic and DNA vaccines. 
2.3 Objectives of Study 
2.3.1 To Generate a Database for Intratypic Variation of Different Gene 
Regions ofHPV58 
The first objective of this study was to build up a sequence database for the 
seven target gene regions of HPV58. This was acquired by large scale sequencing of 
HPV58 DNA isolated from over 400 clinical specimens collected from 15 
cities/countries. A representative database of genetic sequences of HPV58 variants 
was generated. The sequences of each individual gene were stored in common 
formats such as Fasta and Nexus. The sequences will also be submitted to the 
GenBank for public access. 
2.3.2 To Study the Variability of Seven Gene Regions of HPV58 
The variability for each gene region of HPV58 was analysed. The variability of 
each nucleotide position of each target gene region was calculated using a 
mathematical method. More variable or conserved segments in the target gene 
regions were identified for different applications, such as design for primers, probes 
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and management of recombinant proteins for vaccine development. 
2.3.3 To Study the Geographical Distribution of HPV58 Variants 
The geographical distribution of variants was documented and the pattern of the 
distribution was analysed. A system for assessing of the prevalence of each variant 
was established. 
2.3.4 To Study the Phylogeny of HPV58 
The phylogenetic relationships among HPV58 variants were studied by 
constructing phylogenetic trees. The evolution status was determined by calculating 
the dN/dS ratio for each gene region. The clustering pattern and the evolutionary 
characteristics of variants were evaluated for each gene region. 
2.3.5 To Develop an Intratypic Classification System for HPV58 
Based on the sequence information and the phylogenetic analysis results, gene 
regions showing statistically significant clusters were identified. The most significant 
and clear patterns of clustering were used to define the lineages of HPV58. The 
representative nucleotide positions among these clusters were identified as the 
potential markers for lineage differentiation. 
2.3.6 To Predict the Effectiveness of Commonly Used Primers on the Detection 
ofHPV58 
The efficiency of primer sets are affected by the variability of their 
complementary binding sites located in the target gene region. The mismatched 
positions for commonly used primer sets were identified based on the sequence data 
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Chapter Three - Materials and Methods 
3.1 Overall Study Design 
A world-wide cross-sectional analysis on the sequence variation of human 
papillomavirus (HPV) type 58 genome was conducted. Clinical specimens consisting 
of cervical scrapes and cervical biopsies were collected from females attending 
healthcare clinics in different cities/countries from five continents across the world. 
Penile scrapes were collected from males from a healthcare centre in the USA. DNA 
was extracted from the specimens for HPV detection. The presence of HPV58 in the 
specimens were previously detected either by type-specific PGR or by using 
commercial HPV typing kits by our collaborators before the specimens were sent to 
our laboratory. 
After receiving the samples, the quality of the samples was ensured by a 
type-specific PCR. The HPV58 DNA sequences of samples with good DNA quality 
were determined by using polymerase chain reaction (PCR) cycle sequencing. 
Briefly, seven HPV58 gene regions were amplified by a single or a nested PCR. The 
PCR products that were used for the sequencing reaction were carried out using the 
fluorescence-labelled dideoxynucleotide method. Nucleotide sequences of the seven 
gene regions were obtained for subsequent phylogenetic analysis. 
The genetic variability of each gene region was analysed with several 
phylogenetic programs. Primers commonly used in the molecular detection of 
HPV58 were examined. Phylogenetic trees were constructed to describe the 
evolutionary relationship among HPV58 variants. Non-synonymous to synonymous 
substitution rate ratio of each gene was determined to measure the selective pressure 
for each HPV58 gene product. 
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3.2 Study Population 
This is an international collaborative study. Collaborators from across the world 
were invited to contribute their HPV58-positive clinical samples to us for sequence 
determination. A total of 571 specimens, comprising of 521 cervical scrapes and 
biopsy specimens and 50 penile scrapes specimens, were collected, within the period 
from 1996 to 2006. The cervical scrapes and biopsy specimens were collected from 
women attending healthcare clinics for cervical screening from 14 countries or 
regions in five continents across the world. These countries and regions included: 
The mainland China, Hong Kong Special Administrative Region, Taiwan, Korea, 
Japan, Thailand, Great Britain, Italy, Zimbabwe, Canada, Mexico, Argentina, Brazil 
and Honduras. The cervical cytological or pathological findings where available for 
361 subjects were known, with 115 normal, 32 atypical squamous cells of unknown 
significance (ASCUS), 95 low-grade (LG) squamous intraepithelial lesion (SIL) or 
cervical intraepithelial neoplasia (CIN) grade 1, 79 high-grade (HG) SIL or CIN 2/3, 
and 39 invasive carcinomas. The cytology or pathology results of 161 subjects were 
unknown. Furthermore, fifty penile scrape specimens were collected from human 
immunodeficiency virus positive men attending healthcare clinics for the 
management of genital diseases in the United States of America from 1998 to 1999. 
The distribution of the origins of the specimens is summarised in Table 3.1. 
3.3 Sample Processing and Storage 
The specimens were sent in either three forms: extracted DNA, ethanol 
precipitated DNA (dried form) or as cervical cells suspended in phosphate buffer 
saline (PBS). Where appropriate, the DNA from the ethanol precipitation was 
reconstituted in Tris-EDTA (TE) buffer (Qiagen, Hilden, Germany) and the DNA 
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from cervical scrapes were extracted using a commercial kit, QIAamp Blood Kit 
(Qiagen, Hilden, Germany). Briefly, 200 i^L of the cervical scrape specimen was 
added to 200 |iL of AL buffer and incubated at 57°C for 10 minutes. Two hundred 
microlitres of 100% ethanol was added and mixed thoroughly and the mixture was 
applied to a spin column. The column was washed once with AWl, centrifuged at 
6,000 g for 1 minute and washed again with AW2 and centrifuged for 3 minutes at 
20,000 g. The extracted DNA was eluted in 50 i^L of TE buffer. All samples were 
kept frozen at -70°C until further use. 
The quality of the DNA samples and the presence of HPV58 were reconfirmed 
by PGR. 
3.4 Primer Design 
Primers flanking the entire E2, E5, E6/E7, LI, and LCR regions were designed 
for PGR and sequencing. All primers designed were based on the prototype sequence 
of HPV58 (GenBank accession number NC_001443), which was isolated from a 
Japanese woman with cervical cancer. 
The primers were designed in such a way that the primer pair flanks the target 
gene region with at least 40 base-pairs extra space at the 3，direction to allow for the 
sequencing read. All primers were 20 to 22 bps in length, with predicted annealing 
temperatures at about 55 to 60°C in working PGR conditions, and without significant 
secondary structures, such as hair-pins and primer dimers. Selected primer sequences 
were aligned with sequences available in the GenBank to exclude any possibilities of 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter Three - Materials and Methods 
The primer sequences, position numbered according to the HPV58 prototype 
genome (GenBank accession number NC_001443), and the predicted annealing 
temperatures for each gene region are listed in Table 3.2. 
3.5 Specimen Quality Assessment and Sample Selection 
The stored specimens were all first subjected to a screening PGR. A nested 
HPV58 type-specific PGR targeting the E6/E7 region amplifying a segment of 968 
bps in the first round, and of 897 bps in the second round were used to assess the 
DNA quality. Samples that were found to contain at least 20 ng of amplified DNA 
were selected for further sequence analyses. The E6/E7 gene region was selected 
because it is stably retained throughout the viral life cycle, whereas other gene 
regions such as E2 and LI has previously been reported to be disrupted during viral 
integration [Chan et al 2007, Depuydt et al 2007]. 
3.6 Amplification of Gene Region 
A single or nested PGR was performed to amplify the E2, E5, E6/E7, and LCR 
regions. Due to the length of the LI gene, this region was amplified using two 
overlapping PCRs，targeting the Ll-5' region and LI-3，region respectively. 
In the first-round PGR, four microlitres of extracted preparation were added to a 
46-|iL reaction mix, containing PGR buffer at working concentration (Qiagen, Hilden, 
Germany), 200 mM of deoxynucleotide triphosphates (dNTP) (Qiagen, Hilden, 
Germany), forward and reverse outer primers at 0.25 [lM each, 1.25 unit of 
Hotstarra^ Plus polymerase (Qiagen, Hilden, Germany), and nuclease-free water. 
The final 50-|iL PGR reaction mix of each sample was incubated in a 
thermocycler (9700 Applied Biosystems, Foster City, USA). The cycling conditions 
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were at 95°C for 5 minutes for the activation of the polymerase, followed by 40 
cycles of 94°C for 50 seconds, annealing (56-60°C) for 50 seconds, and (50-80 
seconds) 72°C for elongation. A final extension at 72°C for 8 minutes was given for 
each PGR. The annealing temperature and the elongation time required for each gene 
region are listed in Table 3.2. 
The amplification products were visualised by agarose gel electrophoresis. 
Products containing at least approximately 20 ng DNA, were proceeded to sequence 
determination, while those of insufficient quantity were subjected to a second-round 
of PGR. 
In the second round of PGR, two microlitres of the first-round PGR product 
(diluted 100-fold in nuclease-free water) were added to a 48-|xL reaction mix, 
containing PGR buffer at working concentration (Qiagen, Hilden, Germany), 200 
mM of dNTP (Qiagen, Hilden, Germany), forward and reverse inner primers at 0.25 
[iM each, 1.25 unit of HotstarTa^ Plus polymerase (Qiagen, Hilden, Germany), and 
nuclease-free water. 
The final 50-|iL PGR reaction mix of each sample was subjected to 
amplification by PGR, and the quality of the amplified products were determined as 
for the first-round PGR. Products with at least 20 ng of DNA of expected sizes were 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter Three - Materials and Methods 
3.7 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to confirm the size of PGR product and to 
assess the quantities, 1.5 to 2 grams of Seakem LE® agarose powder (Cambrex Bio 
Science, Rockland, USA) was dissolved in 100 mL of boiling IX AccuGENE® 
Tris-Borate-EDTA (TBE) buffer (Cambrex Bio Science, Rockland, USA) to make a 
1.5% to 2% gel, depending on the expected product size. One microlitre of SYBR® 
safe stain (Molecular probes, Invitrogen, Oregon, USA) was added per 100 mL of 
TBE buffer for pre-staining. . 
Five microlitres of PGR product were mixed well with one microlitre of gel 
loading dye and added into a well of the agarose gel immersed in TBE buffer inside a 
gel tank. One hundred and fifty nanograms of PhiX174 RF Hae III Digest marker 
(Amersham Biosciences, Pitcataway, USA) were also loaded on each gel. A voltage 
of 110 V was applied during the electrophoresis. The period of electrophoresis 
depended on the PGR product size. For products smaller than 700 bps, 
electrophoresis was carried out for 40 minutes; 701-1000 bps for 50 minutes; and 
above 1000 bps for 60 minutes. The image of the amplicons was visualised and 
photographed under the exposure of ultraviolet translumination. 
3.8 Sequencing Reaction 
3.8.1 Purification of PGR Product 
Approximately 45 |iL of PGR products were purified by Microspin S-400 
columns (Amersham Biosciences, Pitcataway, USA) to remove unused primers, 
unreacted dNTP, and salts. The column was first centrifuged at 750 g for one minute 
to remove the preserving buffer. The PCR products were gently added onto the resin 
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and centrifuged again at 750 g for two minutes. Approximately 40 j^ L of elute, which 
was the purified PCR product, was obtained. 
3.8.2 Sequencing Reaction 
The purified products used for sequence determination was carried out by the 
fluorescence-labelled dideoxynucleotide approach. Ten microlitres of the purified 
products were mixed with 2 |iL of BigDye® Terminator v.3.1 sequencing reaction 
mix (Applied Biosystems, Foster City, USA), 3 |iL of 5X sequencing buffer (Applied 
Biosystems, Foster City, USA), and 3.2 pmol sequencing primer making up to a final 
volume of 20 pL according to the manufacturer's guideline. The 20-p.L mixture was 
subjected to a labelling PCR, which include 25 cycles at 95�C for 15 seconds, 50°C 
for 15 seconds, and 65°C for 75 seconds. Both sense and antisense strands for each 
gene region were generated in separate reactions to obtain the whole sequence of the 
region. 
3.8.3 Purification of Fluorescence-labelled Product 
The product of the labelling PCR was purified with DyeEx® (Qiagen, Hilden, 
Germany) for the removal of unused primers, unreacted fluorescent-ddNTP, and salts. 
The column was first centrifuged at 800 g for three minutes to remove the preserving 
buffer. Ten microlitres of the PCR product were added onto the resin and centrifuged 
again at 800 g for another three minutes. Approximately 10 |xL of the purified 
product were obtained. Care was taken to prevent the purified products from 
exposure to light, and were kept in the dark until further processing. 
3.8.4 Sequence Identification 
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Two microlitres of the purified product was loaded with 10 i^ L of Hi-Di™ 
formamide (Applied Biosystems, Foster City, USA) solution and then denatured at 
95°C for two minutes. The sequences were generated with an ABI 3130 automated 
sequence analyser (Applied Biosystems, Foster City, USA). The sequences of the 
samples were exported from the analyser and stored as ABI files, a format that 
provides the sequencing chromatogram and the nucleotide sequence in text codes. 
3.9 Sequence Analysis 
3.9.1 Sequence Editing 
The ABI files were analysed by SeqScape® version 2.5 (Applied Biosystems, 
Foster City, USA). Briefly, an analysis project file was first built up for each gene 
region by setting criteria for reading chromatograms and assigning a referent 
sequence for comparison. The ABI files were input to corresponding project files for 
base calling. Sequences in some regions that failed to be called by the program were 
clarified by hand editing. The edited sequences were saved in a Fasta file format for 
subsequent analysis. In case an insertion or deletion was found, it must be based on 
both the forward and reverse sequencing results or repeated sequencing results. For 
insertion or deletion only detected in one sample, the result was confirmed by 
another independent round of sequencing. This confirmatory second sequence reation 
was to confirm the insertion or the deletion found and to eliminate the possibility of 
an error introduced by the Taq polmerase. 
3.9.2 Criteria for Confirming the identity of HPV58 
By definition, an HPV genome with over 90% homology of the LI sequence 
with the HPV58 prototype (NCBI GenBank accession number NC_001443) is 
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regarded as type 58. For isolates with the LI gene successfully sequenced, this 
definition is clear. 
However, there were 40 isolates whose LI gene sequences were not completed 
but the sequences of one or more of their other gene regions were successfully 
obtained. To identify that these isolates belong to HPV58, comparisons of these gene 
sequences between HPV58 and other types in the same species, species a9, were 
made and summarised in Table 3.3. 
Table 3.3 Sequence homology of six HPV prototypes in species a9 with HPV58 
prototype (NC_001443). 
Sequence homology of different gene regions of the 
HPV58 prototype with other HPV types (%) HPV prototype 
LI E6 E7 E2 E4 E5 LCR 
HPV 16 
(NC_001526) 
75.2 67.0 69.7 65.8 52.2 53.7 55.2 
HPV31 
(NC_001527) 
74.7 68.8 68.2 65.1 55.0 57.3 56.9 
HPV33 
(NC 一 0 0 1 5 2 8 ) 
81.6 84.7 87.9 80.8 71.3 80.7 68.8 
HPV35 
(NC_001529) 
73.2 69.7 69.1 64.6 59.6 59.0 54.4 
HPV52 
(NC_001592) 
79.0 74.6 76.8 69.8 56.1 66.0 61.2 
HPV67 
(NC—004710) 
79.0 75.1 75.0 73.9 65.6 64.8 62.6 
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Sequences of different gene regions were aligned with EMBOSS Pairwise 
Alignment Algorithms available at http://www.ebi.ac.uk/Tools/emboss/align/. 
Needleman-Wunsch global alignment algorithm for DNA molecule was used with 
scores of gap open = 10 and gap extension = 1.0. 
The sequence homology between HPV58 and HPV33 was the highest, but was 
still less than 90%. It is reasonable to set, for any isolates without LI gene sequence 
obtained, a cut-off threshold at 95% homology to every gene region to include an 
individual gene region as a variant of HPV58. 
3.9.3 Identification of Variants 
The numbers of isolates with complete sequences for each gene region can be 
found in Table 3.1. All sequences were aligned by CLUSTAL X [Thompson et al 
1994，Thompson et al 1997]. Non-repeated sequences were identified as a variant of 
the gene region. 
Variants were named in the following format: "gene region" - W W - "series 
number". WW stands for "world wide" as the names were assigned according to the 
world wide distribution of the variants. The series numbers of the variants were 
assigned starting with '01' indicating the most prevalent variant for each gene region. 
'Weighed proportion' was computed due to the different number of specimens 
received from each country. If the weight of every specimen was taken as the same, 
the contribution of variants from a country with fewer specimens would be easily 
masked by those from countries with more specimens. It is more reasonable to assign 
every country an equal importance. The 'weighed proportion' of each variant was the 
taken as average value of these percentages. The formula for the calculation of 
weighed proportion is: 
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I Percentage of each variant detected in a country 
Weighed proportion = 
Number of countries 
For two variants with an equal weighed proportion, the series number was 
assigned by their prevalence in terms of the number of specimens in which the 
variant was detected, and then by the alphabetical order of country names. 
A drawback of using weighed proportion in the calculation of the relative 
prevalence of each variant is that a bias may occur when the number of samples 
received from a country is very small, say, less than five. This is because if a variant 
is detected from a country that contained fewer samples, the weight of that variant 
will carry a much bigger weight than a variant that is found from a country that 
contained a bigger sample size. Since a small sample size does not effectively cancel 
out the random sample error but contradictively these samples will carry a heavier 
weight in the calculation of weighed proportion, it could easily cause a bias in the 
true picture in variant distribution. There were altogether three countries, namely 
China, Brazil and Mexico with less than five samples. To see how this effect may 
have on the prevalence distribution of variants, an overall analysis was made to 
include all countries and then a supplementary analysis was carried out when these 
three countries with the less than five samples were omitted. 
3.9.4 Identification of Conserved and Variable Regions 
Entropy is a method to measure the variability of a position within a gene region 
[Thomas 1999]. The entropy of a nucleotide position is given by the following 
equation 
H(p) = - m , P ) In 胸 
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where H(p) is the entropy at position p, and f{b,p) is the frequency at which residue b 
is found at position p. 
For each nucleotide position in a DNA molecule, there are four possible types of 
base variations. The maximum entropy at a particular position is attained when A, T, 
C, and G occur each at 25% of all the samples in the study, and the value is given by 
H (maximum) = - ( 0.25 x In 0.25 ) x 4 = 1.39 
The closer the entropy value is to 1.39, the more variable that position is. On the 
other hand, an entropy value equal to zero indicates that position is conserved. By 
plotting the entropy value for every nucleotide position along a gene region, the 
variability of the gene can be assessed. 
The overall variability of a gene region was estimated by the average entropy 
value at every nucleotide position of a gene region [Chen et al 2006]. The relative 
variability of different gene regions was estimated by comparing their average 
entropy values. 
3.9.5 Phylogenetic Analysis 
The phylogenetic relationship among different HPV58 variants was analysed by 
three softwares: PAUP* 4.0 blO [Swofford 2002], which was used for constructing 
maximum likelihood phylogenetic trees with bootstrap values; MrBayes v3.1.2 for 
constructing Bayesian phylogenetic tree with posterior probabilities; and the 
Datamonkey program, which was used for the calculation of the non-synonymous to 
synonymous substitution rate ratio (dN/dS) of each variant. 
3.9.5.1 Construction of Maximum Likelihood Tree 
A Nexus file was converted from the Fasta file containing non-repeated 
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sequences for each gene. The file was then executed with PAUP* 4.0 blO. For each 
gene region, the best model for nucleotide substitution was estimated with Modeltest 
v3.7 by Akaike Information Criterion (AIC) [Posada and Crandall 1998], through 
which 56 defined models were tested to fit the input sequences. Using the best model, 
a neighbour-joining (NJ) tree was constructed as a starting tree, followed by a 
maximum-likelihood (ML) tree using the subtree pruning and re-grafting (SPR) 
search approach. The trees were displayed with Figtree vl.1.2. 
The variant with sequence equivalent to the HPV58 prototype (GenBank 
accession number NC_001443) was highlighted in the tree. For the E2 and E4 genes, 
where no variant was found to be equivalent to the prototype sequence, a prototype 
sequence was put into the nexus file as a reference sequence in the phylogenetic 
analysis. 
In addition to a ML tree for each individual gene, a tree was also constructed for 
a sequence artificially produced by joining the sequences of E6-E7-E2-E5-L1 -LCR 
together to achieve the maximum information for the HPV58 genome. A 
prototype-like E6-E7-E2-E5-L1-LCR region was also added as a referent sequence. 
3.9.5.2 Bootstrap Analysis 
The bootstrap value for each branch of the optimal ML tree was analysed by 
PAUP* 4.0 blO. Bootstrap is a test of the reliability of branches, by comparing the 
branching patterns of the optimal tree and of pseudotrees generated from 
pseudo-duplicates of samples, which were obtained by the nucleotide replacement 
approach according to the sequence data [Felsenstein 1985, Wrobel 2008]. One 
thousand bootstrap replicates were implemented on every node on the optimal tree, 
and the value indicates the percentage of pseudotrees having the same pattern with 
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the tree at a particular branch. Bootstrap values greater than 50 were recorded in the 
ML trees. 
3.9.5.3 Bayesian Phylogenetic Analysis 
A phylogenetic tree for each gene region was also estimated with the Bayesian 
inference. MrBayes v3.1.2 [Huelsenbeck and Ronquist 2001, Ronquist and 
Huelsenbeck 2003] was used in constructing the tree. The nucleotide substitution 
model for each gene region was set according to the results obtained in Modeltest as 
described. Other prior settings were set as defaults. The Bayesian Markov Chain 
Monte Carlo analysis for each gene region was run for five million generations and 
the trees were sampled every 1000 generations. A burnin rate of 25% was used in 
summarising the data so that the first 25% generations obtained was disregarded in 
the analysis of data. The Bayesian phylogenetic trees were viewed by Figtree vl.1.2. 
For each gene region, the two independent runs offered in the program matched very 
well for their optimal trees, indicating a good probability of finding the global 
optimal tree. 
In the tree, the variant with sequence equivalent to the HPV58 prototype 
(GenBank accession number NC—001443) was highlighted. For the E2 and E4 genes, 
where no variant was found to be equivalent to the prototype sequence, a 
prototype-like sequence was put into the nexus file as a reference sequence in the 
analysis. 
3.9.5.4 Non-synonymous to Synonymous Substitution Rate Ratio (dN/dS) 
The dN/dS value measures the selection pressure of a gene at protein level 
[Yang et al 2000]. A dN/dS value equal to one indicates a neutral selection, larger 
42 
Chapter Three - Materials and Methods 
than one indicates a positive or diversifying selection and less than one indicates a 
negative or purifying selection. The dN/dS value was calculated using datamonkey 
[Pond and Frost 2005, Sergei et al 2005], a program package available online at 
www.datamonkev.org for estimating the dN/dS value with statistical tests. The mean 
dN/dS value for each ORF was calculated with the single likelihood ancestor 
counting (SLAC) method, which is powerful at detecting non-neutral evolution in an 
alignment containing more than 50 sequences, according to the user's menu. 
3.9.6 Evaluation of Performance of Commonly Used Primers 
There are several sets of primers actively utilised by researchers to detect the 
presence of common mucosal HPVs. Five most common sets of primers, including 
PGMY09/11, MY09/11, GP5+/6+, SPF, and LIF/LIR, were evaluated in this study. 
To estimate the performance of these common primers, the primer sequences for 
the detection of HPV58 were determined and aligned to their respective target 
positions in the HPV58 genome. The performance of each primer set was estimated 
base on the percentage match to the target region. 
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Chapter Four 一 Results 
4.1 Specimen Quality Assessment and HPV58 Confirmation 
A total of 571 HPV58 containing specimens were collected from 15 
cities/countries worldwide (Table 3.1). Within these specimens 521 of them were 
cervical scrapes and biopsy specimens, while 50 of them were penile scrapes 
collected from male patients. Altogether there were 13 specimens that were collected 
from repeated subjects and hence were excluded from this study, leaving 558 
specimens from unique subjects. . 
By screening with a HPV58 type-specific nested PGR targeting the E6/E7 
region, 441 (79.0%) specimens were found to contain an adequate quality of HPV58 
DNA. Sequencing was attempted for all the other target gene regions on these 
specimens. 
4.2 HPV58 Genome Variability 
In this phylogenetic study, a total of 4,425 bps of nucleotide sequence was 
investigated, representing 56.6% of the HPV58 complete genome. The sequence 
variability of E2, E4, E5, E6, E7, LI, and LCR was individually described, followed 
by an analysis of the seven gene regions together from the same specimen as a 
whole. 
Almost all variations among different variants of each ORF were nucleotide 
substitutions. Only one insertion and one deletion were observed within the ORFs. 
Both of them were located at the same position 3361-3363, in the E2 and E4 gene, 
and were in-frame indels involving 3 bps in each variant. Indels are more commonly 
observed in the non-coding LCR region, in which a total of nine indels, sized from 1 
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bp to 43 bps, were found. 
4.2.1 E6 Open Reading Frame 
A total of 441 isolates were sequenced for the E6 gene, in which 24 variants 
were identified. One of the variants, named 'E6_WW0r, predominated and 
accounted for 73.7% of the total number of isolates, and with a weighed proportion 
of 78.2 (Appendix I). The five countries with the highest percentage of HPV58 
isolates that belong to this variant included Great Britain (100%), Brazil (100%), 
Mexico (100%), Korea (88.3%), and Thailand (85.7%). The second most prevalent 
variant, E6_WW02, was the prototype-like variant and had a weighed proportion of 
5.7. The weighed proportions of the other 22 variants were all below 5.0. 
To prevent any bias in the calculation of weighed proportion caused by 
countries with less than five specimens, the countries with less than five isolates, 
including China, Brazil and Mexico, were removed from the analysis. In doing so, 
variant E6_WW02 became the third most prevalent variant and the E6_WW03 
would became the second, while the order of the weighed proportions of the other 
variants remained the same. 
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Table 4.1 Five most variable positions in the HPV58 E6 gene. 
Nucleotide Nucleotide Nucleotides observed Type of substitution Point 
position in position in (%) • (amino acid entropy^ 
HPV58 E6 gene change) 
genome 
367 258 C (88.9%), A (11.1%) Missense (Asp, 0.35 
Glu) 
307 198 T (90.2%), C (9.8%) Silent 0.32 
187 79 C (90.2%), T (9.8%) Silent 0.32 
388 279 A(95.9%),C(4.1%) Missense (Glu, 0.17 
• 
Asn) 
245 136 G (97.3%), A (2.0%), Missense (Val, 0.14 
C (0.6%) Ile/Thr, Leu) 
a) Point entropy (H) of a position {p) is calculated by H(p) = -Ifijb.p) \nj{b,p), where is the 
frequency of a type of nucleotide found at that position. The minimum value of entropy is 0 when 
no variation was shown at a position among all variants, while maximum value is 1.38 when A, T, 
G, or C is present and detected at equal frequencies (25% of each). 
the HPV58 E6 gene, based on 441 isolates. 
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The position numbers shown in this figure referred to the positions in the E6 gene, which is equivalent 
to the nucleotide position 110-559 of the HPV58 prototype (GenBank accession number NC_001443). 
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Among these 441 isolates, variations were observed in 22 positions, of which 
the five most variable sites were at nucleotide positions 367, 307, 187, 388 and 245; 
with entropy values of 0.35, 0.32, 0.32, 0.17 and 0.14, respectively (Table 4.1). 
Figure 4.1 shows the entropy plot for each nucleotide position along the 450 bps of 
the E6 gene. The central part of the E6 gene was shown to be relatively more 
variable, while the 150 bps at 3' end was more conserved. The average entropy per 
nucleotide position of the E6 gene was 0.0043. 
Using the Datamonkey program, the average dN/dS value of E6 gene was 
determined to be 1.23 (95% confidence interval 0.78 - 1.81). As the value was not 
significantly different from one, the selection on this gene was regarded as neutral. 
The transversional substitution model with an invariable site assumption 
(TVM+I) was selected as the best-fit model by the Modeltest 3.7 program using AIC. 
Figures 4.2(a) and (b) showed the ML tree and the Bayesian tree of the 24 E6 
variants respectively. The distribution patterns of the two trees were very similar, 
both had a star-like overall pattern. The most prevalent E6 variant, E6_WW01, was 
located at or very close to the centre of both the trees. There were nine variants that 
clustered near the centre of the tree and four comparatively longer branches with 
comparative lengths radiating from it, suggesting four different paths for the 
evolution of this gene. However, the two significant clusters of the E6 gene, as 
illustrated in Figures 4.2(a) and (b), were consisted of only one or two variants. 
Altogether 21 out of the 24 E6 variants were not included in any of the significant 
clusters. 
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Figure 4.2(a) Maximum-likelihood phylogenetic tree of 24 worldwide E6 
variants of HPV58. 
V 
/ 
\ \ \ / / \ \ 
I 
E6 cluster A n 
A maximum-likelihood tree showing the phylogenetic relationship among the 24 E6 variants of 
HPV58 is shown. It was constructed with PAUP* 4.0 using the TVM+I model for nucleotide 
substitution. Bootstrap values were generated with 1000 resamplings. Nodes with bootstrap values of 
greater than 50% are indicated in the figure, while those greater than 70% were regarded as significant. 
The length of the scale bar represents 0.002 substitution per nucleotide position, which is 
approximately equal to 84,000 years (assuming that the nucleotide substitution rate of the E6 gene is 
2.39x10-8 substitution per site per year [Rector et al 2007]). Variant E6_WW02 (highlighted) is 













































































































































































































































































































































































































































































Chapter Four - Results 
4.2.2 E7 Open Reading Frame 
A total of 441 isolates of the E7 gene were sequenced, in which 22 variants 
were identified. Two of the variants, named 'E7_WW01' and 'E7_WW02', 
contributed to 49.7% and 21.1% of the total number of isolates, with weighed 
proportions of 50.3 and 22.6 respectively (Appendix II). The five countries with the 
highest percentage of HPV58 isolates that belong to variant E7_WW01 included 
Great Britain (84.2%), Canada (83.3%), Argentina (71.4%), Italy (68.2%), and Brazil 
(66.7%). The weighed proportions of the other 20 variants were all below 5.0. 
When the sequences from countries that contained less than five samples were 
removed from the list, variant E7_WW08 no longer existed and the weighed 
proportion of E7_WW03 ranked after E7_WW07 and before E7_WW09. The order 
of weighed proportions of the other variants remained unchanged. 
Among the 441 isolates, the five most variable sites were detected at nucleotide 
positions 694, 760，632，793，and 801; with entropy values of 0.69, 0.57, 0.53, 0.40, 
and 0.39 respectively (Table 4.2). All five most common variations involved amino 
acid changes. The average entropy per nucleotide position along the E7 gene was 
0.0173. 
Figure 4.4 shows the entropy value at each nucleotide position along the 297 
bps of the E7 gene. It was shown that the 3'-terminal portion of E7 gene was 
relatively more variable, with at least seven hotspots of nucleotide variations. In the 
5'-terminal portion of E7, there were only two variation hotspots and the portion was 
relatively more conserved. 
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Chapter Four - Results 
Using the Datamonkey program, the average dN/dS value of E7 gene was 
determined to be 0.43 (95% confidence interval 0.25 - 0.68). As the value was 
significantly less than one, the selection on this gene was regarded as negative. An 
amino acid change in E7 protein was more likely to cause a disadvantage to the viral 
life cycle. 
The I lasegawa-Kishino-Yano model with an invariable site assumption (HKY+I) 
was selected as the best-fit model by the Modeltest 3.7 program using AIC. Figure 
4.4(a) shows the ML tree of the E7 variants. The 22 variants were divided into two 
main clusters by the longest stem of the tree passing through variants E7_WW01, 
E7_WW06, E7_WW21, and the putative centre of the eight variants in the lower part 
of the tree. The Bayesian tree (Figure 4.4(b)) showed a similar clustering pattern, 
suggesting two distinct routes in the evolution of the E7 gene. Three significant 
clusters of the E7 variants were observed in the Bayesian tree. Two of them, E7 
clusters A and B, were also significant in the ML tree. Eight out of 22 variants were 
not included in any of the three significant clusters. 
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Figure 4.4(a) Maximum-likelihood phylogenetic tree of 22 worldwide E7 
variants of HPV58. 
E7JW>N20 
81 .9�u^ E7 cluster B 
E7 cluster A 
A maximum-likelihood tree showing the phylogenetic relationship among the 22 E7 variants of 
HPV58 is shown. It was constructed with PAUP* 4.0 using the HKY+I model for nucleotide 
substitution. Bootstrap values were generated with 1000 resamplings. Nodes with bootstrap values of 
greater than 50% are indicated in the figure, while those greater than 70% were regarded as significant. 
The length of the scale bar represents 0.004 substitution per nucleotide position, which is 
approximately equal to 278,000 years (assuming that the nucleotide substitution rate of the E7 gene is 
1.44x10-8 substitution per site per year [Rector et al 2007]). Variant E7_WW04 (highlighted) is 
equivalent to the E7 gene of the HPV58 prototype (GenBank accession number NC_001443). 
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Figure 4.4(b) Bayesian phylogenetic tree of 22 worldwide E7 variants of HPV58. 
E7 cluster B 
I / / 
vy*N20 
E7 cluster C 
E7 cluster A 
A Bayesian tree showing the phylogenetic relationship among the 22 E7 variants of HPV58 is shown. 
It was constructed with MrBayes v3.1.2 using the Bayesian MCMC method. The posterior probability 
was given by the Bayesian credibility values using MrBayes v3.1.2. Nodes with the values of greater 
than 0.50 are indicated in the figure, while those greater than 0.70 were regarded as significant. The 
length of the scale bar represents 0.02 substitution per nucleotide position, which is approximately 
equal to 1.4 million years (assuming that th^ nucleotide substitution rate of the E6 gene is 1.44x10'^ 
substitution per site per year [Rector et al 2007]). Variant E7_WW04 (highlighted) is equivalent to the 
E7 gene of the HPV58 prototype (GenBank accession number NC—001443). 
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4.2.3 E2 Open Reading Frame 
For the E2 gene, a total of 410 isolates were sequenced and 76 variants were 
identified. Two of the variants, named 'E2_WW0r and 'E2_WW02', contributed to 
43.9% and 16.8% of the total number of isolates, with weighed proportions 47.2 and 
13.7 respectively (Appendix III). The top five countries with the highest percentage 
of HPV58 isolates that belong to variant E2_WW01 included Great Britain (81.3%), 
Argentina (71.4%), Brazil (66.7)，Italy (61.9%), and Canada (60.0%). The weighed 
proportions of the other 74 variants were all below 5.0. There were one 
three-base-pair insertion and one three-base-pair deletion in the E2 gene. 
When the countries with less than five isolates sequenced were removed from 
the analysis, variants E2_WW05 and E2_WW07 were removed. The weighed 
proportion of variant E2_WW03 ranked between those of E2_WW09 and 
E7 WW 10, and that of E2 WW06 ranked between those of E2 WW34 and 
E2_WW35. The order of weighed proportion of the other variants remained 
unchanged. 
Among the 410 isolates, the five most variable sites were at nucleotide positions 
3445, 2935, 3685, 3571 and 2932; and with entropy values of 1.00，0.70，0.53，0.45 
and 0.42, respectively (Table 4.3). All the five most common variations did not 
involve any amino acid changes. 
Figure 4.5 shows the entropy value at each nucleotide position along the 1077 
bps of the E2 gene. The 3'-terminal of the E2 gene was relatively more variable, with 
at least eight hotspots of variation (entropy greater than 0.2). In the 5'-half of E2, 
there were only two variation hotspots and this gene segment was more conserved. 
The average entropy per nucleotide position of E2 gene was 0.0068，the second 
lowest among all the genes. 
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Table 4.3 Five most variable positions in the HPV58 E2 gene. 
Nucleotide Nucleotide Nucleotides observed Type of substitution Point 
position at position at (%) (amino acid entropy^ 
genome E2 change) 
3445 693 G (54.9%), C (25.6%), Silent 1.00 
T (19.50/0) 
2935 183 A(45.1%),C(54.6%), Silent 0.70 
T (0.2%) 
3685 933 A (77.8%), G (22.2%) Silent 0.53 
3571 819 G (85.6%), C (0.12%), Silent 0.45 
T( 13.20/0) 
2932 180 G (85.6%), C (0.2%), Silent 0.42 
T(14.1%) 
a) Point entropy (H) of a position (p) is calculated by H(p) = -IJ{b,p) \nj{b,p), where J(b’p) is the 
frequency of a type of nucleotide found at that position. The minimum value of entropy is 0 when 
no variation was shown at a position among all variants, while maximum value is 1.38 when A, T, 
G, or C is present and detected at equal frequencies (25% of each). 
the HPV58 E2 gene, based on 410 isolates. 
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The position numbers shown in this figure referred to the positions in the E2 gene, which is equivalent 
to the nucleotide position 2753-3829 of the HPV58 prototype (GenBank accession number 
NC_001443). 
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Using the Datamonkey program, the average dN/dS value of E2 gene was 
determined to be 0.67 (95% confidence interval 0.60 - 0.75). As the value was 
significantly less than one, the selection on this gene was regarded as negative. That 
means any mutations involving changes in the amino acid sequence were likely to 
bring disadvantages to the evolution of the virus. 
Figure 4.6(a) shows the ML tree of the E2 variants. The transversional 
substitution model with a gamma distribution of rate of variation across the sites and 
a proportion of invariable sites (TVM+I+G) was selected as the best-fit model by the 
Modeltest 3.7 program using AIC. The ML tree had a stem-like pattern with a main 
stem passing through variants E2_WW01, E2_WW39, E2_WW76, E2_WW02, and 
E2_WW07. The overall pattern of the Bayesian tree of the E2 gene (Figure 4.6(b)) 
was similar to that of the ML tree. It contained five significant clusters that radiated 
from the centre of the tree. However, since three out of the five E2 clusters were not 
significant in the ML tree, the overall confidence level of using E2 as the model for 
HPV58 lineage definition was less preferred. 
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Figure 4.6(a) Maximum-likelihood phylogenetic tree of 76 worldwide E2 
variants of HPV58. 
E2 cluster E 
E2 cluster D 
E2 cluster C 
E2 cluster B 
*: bootstrap value 
less than 50.0 
A maximum-likelihood tree showing the phylogenetic relationship among the 76 E2 variants of 
HPV58 is shown. It was constructed with PAUP* 4.0 using the TVM+l+G model for nucleotide 
substitution. Bootstrap values were generated with 1000 resamplings. Nodes with bootstrap values of 
greater than 50% are indicated in the figure, while those greater than 70% were regarded as significant. 
The length of the scale bar represents 0.002 substitution per nucleotide position, which is 
approximately equal to 95,000 years (assuming that the nucleotide substitution rate of the E2 gene is 
2.11X10-8 substitution per site per year [Rector et al 2007]). None of the 76 E2 variants was equivalent 
to the E2 gene of the HPV58 prototype (GenBank accession number NC_001443) and therefore a 









































































































































































































































































































































































































































































































































































Chapter Four - Results 
4.2.4 E4 Open Reading Frame 
A total of 410 isolates of HPV58 E4 gene were sequenced, in which 36 variants 
were identified. Two of the variants, named ‘E4—WWOl’ and 'E4_WW02', 
contributed to 50.5% and 18.8% of the total number of isolates, with weighed 
proportions of 53.5 and 16.8, respectively (Appendix IV). The top five countries with 
the highest percentage of HPV58 isolates that belong to variant E4_WW01 included 
Brazil (100.0%), Great Britain (87.5%), Argentina (71.4), Canada (70.0%), and the 
USA (66.7%). The weighed proportions of the other 34 variants were all below 5.0， 
ranging from 0.1 to 4.3. There was one three-base-pair insertion at prototype 
nucleotide position 3529, and a three-base-pair deletion at 3527-3529 in the E4 gene. 
When the sequences from the three countries that contained less than five 
specimens were removed from the list, variant E4_WW05 was removed, and the new 
weighed proportion of variant E4_WW04 ranked between those of E4_WW07 and 
E4_WW08. The order of weighed proportion of the other variants remained 
unchanged. 
Among the 410 isolates, the five most variable sites were at nucleotide positions 
3445, 3571，3596, 3411, and 3550; and with entropy values of 1.00，0.45, 0.31, 0.30 
and 0.26, respectively (Table 4.4). Four out of the five most common variations 
involved amino acid changes while the other was silent. 
Figure 4.7 shows the entropy value for each nucleotide position along the 276 
bps of the E4 gene. It was shown that the 3'-portion of the E4 gene was slightly more 
variable than the 5'-portion. The more variable nucleotide positions were evenly 
distributed along the gene. The average entropy per nucleotide position of the E4 
gene was 0.0116. 
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Table 4.4 Five most variable positions in the HPV58 E4 gene. 
Nucleotide Nucleotide Nucleotides observed Type of substitution Point 
position at position at (%) (amino acid entropy^ 
genome E4 change) 
3445 116 G (54.9%), C (25.6%), Missense (Tip, Ser, 1.00 
T (19.50/0) Leu) 
3571 242 G (85.6%), T (13.2%), Missense (Cys, 0.45 
C (1.20/0) Phe, Ser) 
3596 267 T(91.0o/o)rG (8.8%), Silent 0.31 
C (0.2%) 
3411 82 A (91.2%), G (8.8%) Missense (Thr, Ala) 0.30 
3550 221 C (92.70/0), T (7.30/0) Missense (Ala, Val) 0.26 
a) Point entropy (H) of a position (p) is calculated by H(p) = -Zj{b,p) \n J{b’p), where X6，p) is the 
frequency of a type of nucleotide found at that position. The minimum value of entropy is 0 when 
no variation was shown at a position among all variants, while maximum value is 1.38 when A, T, 
G, or C is present and detected at equal frequencies (25% of each). 
the HPV58 E4 gene, based on 410 isolates. 
The position numbers shown in this figure referred to the positions in the E4 gene, which is equivalent 
to the nucleotide position 3330-3605 .of the HPV58 prototype (GenBank accession number 
NC—001443). ‘ 
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Using the Datamonkey program, the average dN/dS value for the E4 gene was 
determined to be 0.65 (95% confidence interval 0.42 - 0.94). As the value was 
significantly less than one, the selection on this gene was regarded as negative. That 
means any mutations involving changes in the amino acid sequence of this gene were 
likely to bring disadvantages to the evolution of the virus. 
Figure 4.8(a) shows the ML tree of the E4 variants. Model TVM+I+G was 
selected as the best-fit model by the Modeltest 3.7 program using AIC. The ML tree 
had a main stem joined by three segments of approximately equal lengths, with 
variants E4—WWOl, E4_WW02, E4_WW06, and E4—WW07 as the four nodes on it. 
None of the nodes had a bootstrap value greater than 70, and therefore no significant 
cluster could be identified in this tree. 
Similar to the situation in the E2 gene, the Bayesian tree of the E4 gene (Figure 
4.8(b)) showed an apparently different pattern to the ML tree. There was only one 
significant posterior probability in the tree separating three E4 variants from the 
others, as indicated in the figure. This E4 cluster was not significant in the ML tree. 
There were 33 variants that were not included in the significant cluster. 
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A maximum-likelihood tree showing the phylogenetic relationship among the prototype-like E4 gene 
and the 36 E4 variants of HPV58 is shown. It was constructed with PAUP* 4.0 using the TVM+I+G 
model for nucleotide substitution. Bootstrap values were generated with 1000 resamplings. Nodes 
with bootstrap values of greater than 50% are indicated in the figure, while those greater than 70% 
were regarded as significant. The length of the scale bar represents 0.003 substitution per nucleotide 
position, which is approximately equal to 154,000 years (assuming that the nucleotide substitution rate 
of the E4 gene is 1.95x10'® substitution per site per year [Rector et al 2007]). None of the 36 E4 
variants was equivalent to the E4 gene of the HPV58 prototype (GenBank accession number 
NC_001443) and therefore a prototype-like sequence (highlighted in the tree) was added for reference. 
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Figure 4.8(a) Maximum-likelihood phylogenetic tree of 36 worldwide E4 
variants of HPV58. 
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A Bayesian tree showing the phylogenetic relationship among the 36 E4 variants of HPV58 is shown. 
It was constructed with MrBayes v3.1.2 using the Bayesian MCMC method. The posterior probability 
was given by the Bayesian credibility values using MrBayes v3.1.2. Nodes with the values of greater 
than 0.50 are indicated in the figure, while those greater than 0.70 were regarded as significant. The 
length of the scale bar represents 0.006 substitution per nucleotide position, which is approximately 
equal to 308,000 years (assuming that the nucleotide substitution rate of the E4 gene is 1.95x10"^ 
substitution per site per year [Rector et al 2007]). None of the 36 E4 variants was equivalent to the E4 
gene of the HPV58 prototype (GenBank accession number NC—001443) and therefore a 
prototype-like sequence (highlighted in the tree) was added for reference. 
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4.2.5 E5 Open Reading Frame 
A total of 421 isolates for the E5 region were sequenced, and 47 variants were 
identified. Two of the variants, named 'E5_WW0r and 'E5_WW02', contributed to 
48.2% and 22.1% of the total number of isolates, with weighed proportions of 52.2 
and 24.9, respectively (Appendix V). The top five countries with the highest 
percentage of HPV58 isolates that belong to variant E5_WW01 included Brazil 
(100.0%), Canada (87.5%), Great Britain (86.7%), Argentina (70.0%), and Italy 
(66.7%). The weighed proportions of the other 45 variants were all below 5.0. 
When the three countries with less than five isolates were removed from the 
analysis, the weighed proportion of variant E5_WW06 ranked after that of 
E5_WW14 and before that of E5_WW15. The order of the weighed proportion of the 
other variants remained unchanged. 
Among the 421 isolates, the five most variable sites were at nucleotide positions 
3949，3988, 3957, 4047 and 3930; and with entropy values of 0.70, 0.69, 0.38，0.36, 
and 0.32, respectively (Table 4.5). All the five most common variations did not 
involve any amino acid changes. 
Figure 4.9 shows the entropy value of each nucleotide position along the 231 
bps of the E5 gene. Two relatively more variable regions were observed in the region 
from nucleotides 30 to 100 and in the region from nucleotides 135 to 160 of the E5 
gene. Within a 70-bp region near the 3,-end of E5 gene, no nucleotide position with 
an entropy value greater than 0.1 was observed indicating that this region was more 
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Chapter Four - Results 
Using the Datamonkey program, the average dN/dS value for the E5 gene was 
determined to be 0.30 (95% confidence interval 0.20 - 0.44). As the value was 
significantly less than one, the selection on this gene was regarded as a negative 
selection, which means that any mutations involving changes in the amino acid 
sequence were likely to bring disadvantages to the evolution of the virus. 
Figure 4.10(a) and 4.10(b) show the ML and the Bayesian phylogenetic trees of 
the E5 variants. Model TVM+I+G was selected as the best-fit model by the 
Modeltest 3.7 program using AIC and was used in building the phylogenetic trees. 
The patterns of variant distribution were very similar in the two phylogenetic trees. 
Both trees had a star-like pattern with the E5_WW02 variant located at or close to 
the centre, radiating all other variants into four clusters. There were six nodes in the 
ML trees (Figure 4.10(a)) with bootstrap values greater than 50, but only one of them 
was greater than 70，which is the cut-off for significance. 
Figure 4.10(b) shows the Bayesian tree of the 47 E5 variants. The pattern of this 
tree was similar to that of the ML tree, and the confidence levels suggested by the 
posterior probability were generally more significant. There were four significant E5 
clusters observed in the Bayesian tree, while only one, cluster B, was significant in 
the ML tree. However only less than one third of the E5 variants were included in the 
cluster, but 32 out of 47 E5 variants were not included in any of the four significant 
E5 clusters. 
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Figure 4.10(a) Maximum-likelihood phylogenetic tree of 47 worldwide E5 
variants ofHPV58. 
E5 cluster D 
E5 cluster B 
E5 cluster C 
E5 cluster A 
A maximum-likelihood tree showing the phylogenetic relationship among the 47 E5 variants of 
HPV58 is shown. It was constructed with^PAUP* 4.0 using the TVM+I+G model for nucleotide 
substitution. Bootstrap values were generated with 1000 resamplings. Nodes with bootstrap values of 
greater than 50% are indicated in the figure, while those greater than 70% were regarded as significant. 
The length of the scale bar represents 0.004 substitution per nucleotide position, which is 
approximately equal to 205,000 years (assuming that the nucleotide substitution rate of the E5 gene is 
1.95x10—8 substitution per site per year [Rector et al 2007]). Variant E5_WW18 (highlighted) is 
equivalent to the E5 gene of the HPV58 prototype (GenBank accession number NC_001443). 
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Figure 4.10(b) MrBayes phylogenetic tree of 47 worldwide E5 variants of 
HPV58. 
E5 cluster D 
U u ^ 
E5 cluster C 
A Bayesian tree showing the phylogenetic relationship among the 47 E5 variants of HPV58 is shown. 
It was constructed with MrBayes v3.1.2 using the Bayesian MCMC method. The posterior probability 
was given by the Bayesian credibility values using MrBayes v3.1.2. Nodes with the values of greater 
than 0.50 are indicated in the figure, while greater than 0.07 were regarded as significant. The length 
of the scale bar represents 0.07 substitution per nucleotide position, which is approximately equal to 
3.6 million years (assuming that the nucleotide substitution rate of the E5 gene is 1.95x10"® 
substitution per site per year [Rector et al 2007]). Variant E5_WW18 (highlighted) is equivalent to the 
E5 gene of the HPV58 prototype (GenBank accession number NC_001443). 
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4.2.6 LI Open Reading Frame 
A total of 401 isolates of the LI gene were sequenced, in which 128 variants 
were identified. Three of the variants, named ‘Ll_WW00r， 'L1_WW002', and 
'L1_WW003' contributed to 26.7%, 11.7%, and 3.5% of the total number of isolates, 
with weighed proportions of 33.2, 11.4 and 5.4, respectively (Appendix VI). The top 
five countries with the highest percentage of HPV58 isolates that belonged to variant 
L1_WW001 included Brazil (100.0%), Great Britain (64.3%), Canada (50.0%), 
Mexico (50.0%), and Italy (35.3%). The weighed proportions of the other 125 
variants were all below 5.0，ranging from 0.1 to 3.2. Altogether, 84 of the 128 LI 
variants appeared only once among the 401 isolates, 21 of them appeared twice, and 
the remainder appeared in three or more isolates. 
When the sequences from countries that contained very few samples were 
removed from the list, variants L1_WW004 and L1_WW009 were removed and the 
weighed proportions of L1_WW006 and L1_WW007 ranked between those of 
LI WW035 and LI WW036, and those of LI WW063 and LI WW064, — — ‘ — —. • 
respectively. The order of the weighed proportion of the other variants remained 
unchanged. 
Among the 421 LI isolates, the five most variable sites were at nucleotide 
positions 6641, 6416，6434，6827, and 6014; and with entropy values 0.82，0.69，0.69， 
0.69 and 0.54，respectively (Table 4.6). Four out of the five most common variations 
did not involve any amino acid changes. 
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Table 4.6 Five most variable positions in the HPV58 LI gene. 
Nucleotide Nucleotide Nucleotides observed Type of substitution Point 
position at position at (%) (amino acid change) entropy^ 
genome LI 
6641 1077 A(50.1%),G(46.4%), Silent 0.82 
C (3.5%) 
6416 852 G(53.6%i,A(46.4%) Silent 0.69 
6434 870 C (53.6%), T (46.4%) Silent 0.69 
6827 1263 C (62.8%), A (36.7%), Silent 0.69 
T (0.5%) 
6014 450 C (77.1%), A (22.9%) Missense (Phe, Leu) 0.54 
a) Point entropy (H) of a position (p) is calculated by H(p) = -IAb,p) \nj(b,p)’ where/ft,p) is the 
frequency of a type of nucleotide found at that position. The minimum value of entropy is 0 when 
no variation was shown at a position among all variants, while maximum value is 1.38 when A, T, 
G, or C is present and detected at equal frequencies (25% of each). ，， 
Figure 4.11 Entropy plot for each nucleotide position along the 1575 base pairs 
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The position numbers shown in this figure referred to the positions in the LI gene, which is equivalent 
to the nucleotide position 5565-7139 .of the HPV58 prototype (GenBank accession number 
NC—001443). 
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Figure 4.11 shows the entropy value of each nucleotide position along the 1,575 
bps of the LI gene. Overall, the 3'-portion of the LI gene was relatively more 
variable, where higher entropy values were observed. The region between 
nucleotides 500 and 830 of LI gene (corresponding to nucleotide position 6064 to 
6394 relative to HPV58 prototype genome) was observed to be a more conserved 
region in which no position had an entropy value greater than 0.1. The average 
entropy per nucleotide position of the LI gene was 0.0110. 
Using the Datamonkey program, the average dN/dS value of LI gene was 
determined to be 0.18 (95% confidence interval 0.15 - 0.22). As the value was 
significantly much less than one, the selection on this gene was regarded as negative, 
suggesting that any mutations involving changes in the amino acid sequence were 
likely to bring disadvantages to the evolution of the virus. 
For estimating the nucleotide substitution model, the General Time Reversible 
model with a gamma distribution of rate of variation across sites and a proportion of 
invariable sites (GTR+I+G) was selected as the best-fit model for the LI gene as 
selected by the Modeltest 3.7 program using AIC. 
Figures 4.12(a) and 4.12(b) show the ML tree and the Bayesian tree of the 128 
LI variants respectively. In the ML phylogenetic tree, three clear clusters were 
clearly formed; clusters A, B, and C. The remaining branches in the trees were 
assigned as cluster D. 
The Bayesian phylogenetic tree matched well with the ML tree, except that the 
evolutionary distance between LI cluster A and C in the Bayesian tree was closer. 
The significance as reflected by posterior probabilities in the Bayesian phylogenetic 
tree was generally higher than 0.70, which was regarded as statistically significant. 
Of the 401 isolates of the LI gene, 128 variants were identified. The number of 
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variants identified was the largest among all open reading frames of the HPV58 
genome under investigation. The LI gene was found to be a good region for studying 
the phylogenetic relationship among isolates since four clusters were clearly 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter Four - Results 
The nucleotide markers for each of the four cluster of the LI gene are listed in 
Table 4.7. The unique markers for each LI clusters, for example 6416G and 6641A 
in cluster A; 5579C and 5747C in cluster C; and 6798G and 6828G in cluster D，were 
found. 
Table 4.7 Molecular markers for phylogenetic clusters of LI gene. 
5 5 6 6 6 6 6 6 6 6 6 6 ^ 
Name of 5 7 0 4 4 4 5 6 7 8 8 8 
LI cluster 7 4 1 0 1 3 3 4 . 9 2 2 2 
9 7 4 ' 4 6 4 9 1 ‘‘ 
Cluster A A 1 ， C G G ( ： G A A G C ： A 
Cluster B A 1 ， A A/G A 1 r A G A G C ； A 
Cluster C C ( ： C G A 1 r G G A G � 1 A 
Cluster D A 1 ： A A A 1 r A/G G G A ^ . G 
These 12 nucleotide positions contained molecular markers specific for each of the four LI clusters. 
The unique markers for each cluster were bolded. The numbers of these positions were based on the 
HPV58 prototype (GenBank accession number NC一001443) 
a) 6014 and 6827 were positions of 'combined markers' with the minimal nucleotides involved, in 
which only two positions were sufficient for cluster identification. 6014C-6827C gave cluster A, 
6014A-6827C gave cluster B, 6014C-6827A gave cluster C, and 6014A-6827A gave cluster D. 
b) 6641, 6798, 6822，6827, and 6828 were another set of 'combined markers' within the smallest 
genomic distance for cluster discrimination. A sequence coverage of 188 bps was sufficient for 
cluster identification. At the five positions respectively, A-A-G-C-A will identify cluster A, 
G-A-G-C-A cluster B, G-A-G-A-A cluster C, and G-G-A-A-G will give cluster D. 
Combinations of nucleotide positions forming 'combined markers' for the 
identification of each cluster were determined. The combination that involved the 
minimal number of nucleotides was observed at two positions, 6014 and 6827. 
Identification of the nucleotide at these two positions was sufficient to define the LI 
variant into the defined cluster. For instance, an HPV58 isolate with A at 6014 and C 
at 6827 belonged to LI cluster B. Table 4.7 showed the molecular markers that 
classified the LI variants into four clusters. 
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Another group of ‘combined markers' within the shortest genomic distance 
included five positions 6641，6798, 6822, 6827, and 6828. These five positions were 
located within a 188 bps segment on the LI gene and their sequence information 
could readily be obtained using one sequencing reaction. For instance, an HPV58 
isolate with A-A-G-C-A at the five positions belonged to LI cluster A. 
In addition to DNA sequencing, restriction fragment length polymorphism 
(RFLP) that involves the cleavage at the specific sites on the sequence can also be 
used for cluster identification. A fragment of DNA between position 6269 and 6887 
of the HPV58 genome can be amplified by PCR with a forward primer 
(5 '-CTTTGGTACATTGCAGGCTAA) and a reverse primer (5'-GTCCTGTAAA 
CTGGCAGACG). The predicted pattern of restriction digestion is shown in Figure 
4.13. The restriction enzyme BstEII recognises specifically the site G|GTNACC, 
which appeared once in the amplicon. This enzyme will restrict at the position 6539 
of the HPV58 isolates of LI clusters A and C. All isolates from cluster B would be 
resistant to the restriction. Isolates of cluster D might contain an A or a G at 6539, 
and thus they might or might not be restricted by this enzyme. 
BsaJI is a restriction enzyme that recognises specifically the site C|CNNGG, 
which appeared once in the amplicon. BsaJI will restrict at position 6637 of variants 
from LI clusters B, C, and D，but not those from cluster A since they had an A rather 
than a G at position 6641. 
Sspl recognise specifically the site AAT|ATT, which appeared once in the 
amplicon. The enzyme will restrict at position 6830 of variants from LI clusters A, B, 
and C, but not those from cluster D as this cluster possessed a G rather than an A at 
position 6828. 
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Figure 4.13(aHc) RFLP outline for HPV58 LI cluster identification. 
By prediction, an amplicon within positions 6269 to 6887 of the HPV58 genome can be generated by 
PGR using the forward primer (5 '-CTTTGGTACATTGCAGGCTAA) and the reverse primer 
(5 '-GTCCTGTAAACTGGCAGACG). Three restriction enzymes, namely BstEII, BsaJI, and Sspl 
could be added at the same time to the PGR product and incubated for complete digestion. The 
restriction sites of these enzymes are illustrated in Figure (a) and listed in Table (b). Different LI 
clusters of HPV58 would show different patterns of fragments as illustrated in the diagram. The 
restriction patterns for the four LI clusters are listed in Table (c). 
(a) Position on the LI gene amplicon showing the restriction sites of three endonucleases, 
BstEII, BsaJI, and Sspl for the identification of LI clusters 
6269 6539 6637 6830 6887 
270 bp 98 bp 197 bp 59 bp 
(b) Restriction sites for cluster identification using the three suggested endonucleases 
Nucleotide position of Restriction enzyme LI clusters susceptible to restriction 
recognition sites 
6539 BstEII A, C, and/or D " 
6637 BsaJI B, C, and D 
6830 Sspl A, B, and C 
a) HPV58 of Cluster D may or may not be restricted by BstEII at position 6539. 
(c) Restriction patterns of the four LI clusters by using RFLP. 





59’ 270’ 291 
59, 193,368 
59’ 98，193,270 
98, 252, 270 OR 252, 368 
Complete digestion of the amplicon by the three endonucleases can be 
performed at the same time, the restriction patterns for the four LI clusters are 
summarised in Figure 4.13. Upon complete digestion, the four LI clusters with 
fragments can easily be identified by agarose gel different lengths of DNA 
electrophoresis. 
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The geographical distribution of the four LI clusters is summarised in Tables 
4.8 and 4.9. 
The LI cluster A (53.7%) was the most frequently detected cluster of HPV58 in 
the world, followed by cluster C (21.3%), cluster D (13.8%) and cluster B (11.1%). 
Out of all the countries that harboured cluster A, 100% of Great Britain's and Brazil's 
isolates were of this cluster, Canada came very close at 90.0%, followed by Italy 
(76.4%), USA (68.9%), Argentina (66.7%), Honduras (60.0%), Korea (54.6%), 
Thailand (50.0%), Zimbabwe (47.8%), Hong Kong (40.0%) and Japan (28.6%). 
The LI cluster B was the least prevalent cluster of HPV58 worldwide. Hong 
Kong carried 28.3% of this cluster followed by USA (10.8%), Korea (6.7%) and 
Zimbabwe (2.9%). The other countries contained only one isolate in this cluster, 
these were China (33.3%), Japan (7.1%) and Italy (5.9%). When the analysis focused 
on this cluster by continents, a slight tendency of this cluster seem to reside in Asia 
(18.1%), and especially in East Asia, where it was found to contain the highest 
proportion of this LI cluster (31.6%). On the other hand, Europe (3.0%), Africa 
(2.9%) and America (1.8%) contained relatively lower proportions as detected from 
their isolates. Interestingly, this LI cluster was not detected in Thailand, Great 
Britain, Canada, Mexico, Argentina, Brazil and Honduras. 
The LI cluster C, the second most common cluster in this analysis, was another 
cluster found to be more common in the Asia continent. Half of the LI isolates from 
Taiwan, Japan and Thailand were of this cluster; Korea contained 36.1% followed by 
Hong Kong at 26.1%. In terms of distribution by continents, it was detected in 40.9% 
of isolates from Asia, 9.6% in America, 3.0% in Europe, while Africa did not contain 
this cluster in any of their isolates. 
The LI cluster D which was the third most common cluster in this worldwide 
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Study was particularly more frequently detected in Africa. In terms of continent 
distribution, it was detected in 49.2% of the HPV58 isolates from Africa, while only 
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Chapter Four - Results 
4.2.7 Long Control Region 
For this region, a total of 419 isolates were sequenced, in which 123 variants 
were identified. Four of the variants, named 'LCR_WW001', 'LCR_WW002', 
'LCR_WW003', and 'LCR_WW004' contributed to 11.5%, 20.8%, 6.2% and 3.3% 
of total number of isolates, with weighed proportions 22.1, 22.0, 9.2, and 6.7 
respectively (Appendix VII). The weighed proportions of the other 119 variants were 
all below 5.0, ranging from 0.1 to 2.3. Seventy-nine of the LCR variants occurred 
once in the 419 isolates, 18 of them occurred twice, and the remaining 26 were 
detected in three or more isolates. 
There were 11 types of indels detected in the LCR. The most common indel was 
a 12-bp insertion at nucleotide position 7277 observed in 89 (21.2%) LCR isolates. A 
five-base-pair deletion at 7185-7189 was observed in 37 (8.8%) LCR isolates. Most 
surprisingly, there was a 43-bp insertion in LCR observed in two (0.5%) isolates. 
When the sequences from countries that contained less than five specimens 
were removed from the analysis, the prevalence of variant LCR_WW001 ranked 
between those of LCR_WW002 and LCR_WW004, LCR_WW003 ranked between 
those of LCR_WW004 and LCR_WW006, while LCR_WW005 ranked between 
those of LCR_WW065 and LCR_WW066. The order of prevalence of the other 
variants remained unchanged. 
Among the 419 isolates, the five most variable sites were at nucleotide positions 
7714, 7266, 52, 7146，and 7194; and with entropy values 1.00，0.69，0.67，0.54, and 
0.52, respectively (Table 4.10). 
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Table 4.10 Five most variable positions in the HPV58 LCR gene. 
Nuclotide Nuclotide Nucleotides observed (%) Point entropy^ 
position at position at 
genome LCR 
7714 588 G (55.1%), A (23.6%), C (21.2%) 1.00 
7266 127 T (55.4%), C (44.6%) 0.69 
52 737 C (63.2%), T (36.5%), G (0.2%) 0.67 
7146 8 G (78.3%), T (21.5%), A (0.2%) 0.54 
7194 55 G (764%), C (21.5%) 0.52 
a) Point entropy (H) of a position (p) is calculated by H O ? ) =-聊,p ) \nj{b,p), where 八b’p�is the 
frequency of a type of nucleotide fouftd at that position. The minimum value of entropy is 0 when 
no variation was shown at a position among all variants, while maximum value is 1.38 when A, T, 
G, or C is present and detected at equal frequencies (25% of each). ‘ ‘ 
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The position numbers shown in this figure referred to the positions in the LCR, which is equivalent to 
the nucleotide position 7139-109 of the HPV58 prototype (GenBank accession number NC 一 0 0 1 4 4 3 ) . 
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Figure 4.14 shows the entropy value for each nucleotide position along the 850 
bps of the LCR. The LCR was observed to be the most variable region in the HPV58 
genome. The average entropy per nucleotide position in the LCR was 0.0292, the 
highest among all seven gene regions analysed in this study. 
The variable nucleotide positions were evenly distributed along the LCR, except 
in the region between nucleotide positions 410 and 580 (corresponding to nucleotide 
positions 7562 to 7732 of the HPV58 prototype genome), which was observed to be 
relatively more conserved; with no position found to contain an entropy value greater 
than 0.15. 
Figure 4.15(a) shows the ML tree of the 123 LCR variants. Model GTR+I+G 
was selected as the best-fit model by the Modeltest 3.7 program using AIC. There 
were 123 variants identified from 419 isolates of the LCR. The number of variants 
identified was similar to that of the LI ORF, despite the length of LCR is only about 
half of that of the LI gene. Five LCR clusters were clearly observed in the 
phylogenetic tree. However, the clusters A, B, and C were not separated by 
statistically significant nodes, and hence were not regarded as different clusters. 
The Bayesian phylogenetic tree (Figure 4.15(b)) looked very similar to the ML 
tree. The five clusters of the LCR variants were also easily distinguished in the 
Bayesian tree. However, as in the ML tree, the LCR clusters A, B, and C were not 
separated by posterior probability greater than 0.70, and hence were not regarded as 
statistically significant groups. 
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Figure 4.15(a) Maximum-likelihood phylogenetic tree of 123 worldwide LCR 
variants of HPV58. 
LCR Cluster E 
LCR Cluster A 
*: bootstrap value less 
than 50.0 
LCR Cluster D 
A maximum-likelihood tree showing the.phylogenetic relationship among the 123 LCR variants of 
HPV58 is shown. It was constructed with PAUP* 4.0 using the GTR+I+G model for nucleotide 
substitution. Bootstrap values were generated with 1000 resamplings. Nodes with bootstrap values of 
greater than 50% are indicated in the figure, while those greater than 70% were regarded as significant. 
The length of the scale bar represents 0.003 substitution per nucleotide position, which is 
approximately equal to 112,000 years (assuming that the nucleotide substitution rate of the LCR gene 
is 2.69x10.8 substitution per site per year [Rector et al 2007]). Variant LCR_WW009 (highlighted) is 
equivalent to the LCR of the HPV58 prototype (GenBank accession number NC_001443). 
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LCR Cluster D 
LCR Cluster C 
LCR_WW009 
=Prototype-like 
LCR Cluster B 
LCR Cluster A 
*: posterior probability less 
than 0.50 
A Bayesian tree showing the phylogenetic relationship among the 123 LCR variants of HPV58 is 
shown. It was constructed with MrBayes v3.1.2 using the Bayesian MCMC method. The posterior 
probability was given by the Bayesian credibility values using MrBayes v3.1.2. Nodes with the values 
of greater than 0.50 are indicated in the figure, while those greater than 0.70 were regarded as 
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Figure 4.15(b) Bayesian phylogenetic tree of 123 worldwide LCR variants of 
HPV58. 
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significant. The length of the scale bar represents 0.2 substitution per nucleotide position, which is 
approximately equal to 8.4 million years (assuming that the nucleotide substitution rate of the LCR 
gene is 2.39x10"^ substitution per site per year [Rector et al 2007]). Variant LCR_WW009 
(highlighted) is equivalent to the LCR of the HPV58 prototype (GenBank accession number 
NC_001443). 
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4.2.8 Whole HPV genome 
The six gene regions for each isolate were consecutively joined to give a 
E6-E7-E2-E5-L1-LCR to try and maximise the information of the HPV58 genome 
for each isolate. There were a total of 380 specimens that had all the six gene regions 
successfully sequenced, and altogether 268 different variants of 
E6-E7-E2-E5-L1-LCR regions were identified. Only two of them were with weighed 
proportion greater than 5.0 (Appendix VIII). 
When the three countries with less than five isolates were removed from the 
analysis, variants 58_WW003, 58_WW007, 58_WW008, and 58_WW009 no longer 
existed. The weighed proportion of variant 58_WW001 ranked just after that of 
58_WW002, which became the most prevalent variant. The weighed proportion of 
variant 58_WW005 ranked between those of 58—WW096 and 58—WW097，and 
variant 58_WW006 ranked between those of 58_WW107 and 58_WW108. The 
order of weighed proportion of the other variants did not change. 
The ML and the Bayesian phylogenetic trees (Figure 4.16(a) and (b)) looked 
almost identical for the E6-E7-E2-E5-L1 -LCR sequences. Four statistically 
significant clusters were clearly identified in the tree. The pattern of the tree for the 
E6-E7-E2-E5-L1-LCR region was most similar to that of the LI ORF, which also 
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4.3 Evaluation of Commonly Used Primers 
There are at least five primer systems, including PGMY09/11, MY09/11, 
GP5+/6+，SPF, and LIF/LIR targeting the LI gene of HPV commonly used in the 
epidemiological and natural history studies on HPV. In this study, the primer 
sequences in the above systems were aligned with the HPV58 LI variants identified 
from this study, and as well as with the HPV58 reference prototype (GenBank 
accession number NC_001443). The alignments are shown in Tables 4.11 - 4.25. 
4.3.1 PGMY09/11 Primers 
For the PGMY09/11 primers, the forward (5 '-GCACAGGGACATAACAATGG) 
and reverse (5'-CGTCCCAAAGGAAACTGATC) primer pair [Gravitt et al 2000]， 
that has a propensity to amplify HPV58 is located at nucleotide positions 6588 to 
6607 and 7017 to 7036 of prototype genome (GenBank accession number 
NC一001443)，respectively. By direct comparison and alignment, two nucleotide 
mismatches between the primer and the LI variants were observed. Two mismatches 
were found in the PGMYll forward primer at the sixth and the ninth positions from 
the 5'-end, with 99.3% and 100.0% of isolates showing a mismatch in these positions 
respectively (Table 4.11). 
4.3.2 MY09/11 Primers 
For MY09/11 primer set, the forward (5 ‘ -GCMCAGGGWCATAAYAATGG) 
and reverse (5 '-CGTCCMARRGGAWACTGATC) primer pair [Ting and Manos 
1990] that has a propensity to amplify HPV58 is located at nucleotide positions 6588 
to 6607 and 7017 to 7036 of prototype genome respectively. By direct comparison 
and alignment, one nucleotide mismatch was observed. This mismatch was located at 
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the sixth position from the 5'-end of the forward primer, Table 4.20. Totally 99.3% of 
HPV58 isolates harboured this mismatch (Table 4.12). 
4.3.3 GP5+/6+ Primers 
For GP5+/6+ primer set, the forward (5 '-TTTGTTACTGTGGTAGATACTAC) 
and reverse (5，—GAAAAATAAACTGTAAATCATATTC) primer pair [de Roda 
Husman et al 1995] that has a propensity to amplify HPV58 is located at the HPV58 
prototype genome at nucleotide positions 6630 to 6652 and 6744 to 6768 
respectively. By direct comparison and alignment, a total of nine mismatches 
between the primer pair and the LI variants were found. Five mismatches were 
identified to reside in the GP5+ forward primer at the ninth, 12th, 15th, 20th, and 
21st positions from the 5'-end; with 100.0%, 53.6%, 100.0%，0.2%, and 100.0% 
isolates respectively that harboured these mismatches. Another four mismatches were 
detected in the GP6+ reverse primer at the fifth, seventh, 17th, and 25th positions 
from the 5'-end; with 0.2%, 100.0%, 100.0%, and 0.2% isolates respectively that 
harboured these mismatches (Table 4.13). 
4.3.4 SPF Primers 
For SPF primer set, one forward primer (5'-GCICAGGGICATAACAATGG) 
and two reverse primers (5'-GTIGTATCIACAACAGTAACAAA and 5'-GTIGTA 
TCIACATCAGTAACAAA) [Kleter et al 1998] that have a propensity to amplify 
HPV58 were investigated. The forward and reverse primers are located at the 
prototype genome at nucleotide positions 6588 to 6607 and 6630 to 6652 
respectively. By direct comparison and alignment, four nucleotide mismatches 
between the primers and the LI variants were detected. One mismatch was found to 
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reside in the forward primer at the 6th position from the 5'-end, where 99.3% of the 
isolates harboured a nucleotide which did not match with this position. The other 
three mismatches were identified at the fourth, 12th, and 15th positions from the 
5'-end of the reverse primers, with 0.2%, 49.9%, and 100% of isolates respectively 
that harboured these mismatches (Table 4.14). 
4.3.5 LIF/LIR Primers 
For LlF/LlR primer set, the forward (5'-CGTAAACGTTTTCCCTATTTTTTT) 
and reverse (5'-TACCCTAAAGACCCTATACTG) primer pair [Jeney et al 2007] 
that has a propensity to amplify HPV58 is located at prototype genome at nucleotide 
positions 5615 to 5637 and 5850 to 5870 respectively. By direct comparison and 
alignment, a total of five nucleotide mismatches between the primer pair and the LI 
variants were identified. Two mismatched positions were found in the LIF forward 
primer at the 15th and 16th positions from the 5'-end; where 100.0% and 0.2% of 
isolates harboured the mismatch with the forward primer respectively. The other 
three mismatched positions were detected in the LIR reverse primer at its first, 
fourth, and tenth positions from the 5'-end; where 100.0%, 0.2%, and 9.4% of the 
isolates did not have a complementary base with the reverse primer respectively 
(Table 4.15). 
The information on above HPV58-related primers, including the coverage 
positions, mismatched positions, number of degenerate positions, and the variability 
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Chapter Five - Discussion 
Chapter Five - Discussion 
5.1 Overall Variation of HPV58 Genome 
HPV58 is a close relative of HPV16 since they both belong to the same alpha 
species of HPV [de Villier et al 2004]. It is a high-risk HPV type, with a worldwide 
prevalence of 3.3% in cervical cancer, occupying the sixth rank among the most 
prevalent types [Castellsague et al 2007]. HPV58 plays a more important role in 
some areas in the world. It is more commonly found in carcinoma cases in many 
countries and regions in East Asia including Hong Kong and the mainland China [Lai 
et al 1999，Liaw et al 1995, Huang et al 1997, Lin et al 1998，Chan et al 1999, Dai et 
al 2007, Qiu et al 2007]. The higher prevalence of this HPV type in this locality has 
provided a good opportunity for the ease of sample recruitment for the investigation 
of this virus and to provide data which are of most importance to the people in this 
region. In addition to this, samples from other regions of the world were also 
collected. Data from this study has elucidated nucleotide variations of the HPV58 
genome which could be used to generate the first and largest database on the 
international genomic sequence information of HPV58. This database is instrumental 
for future epidemiologic and phylogenetic research use. 
This study has shown that the overall sequence variation of HPV58 genome was 
low. Four of the seven genes had less than 50 sequence variants detected in more 
than the 400 isolates that were analysed. This was in line with previous studies, 
which reported that the HPV genomic sequence can take as long as 10,000 to 
100,000 years to generate only about 1% diversity [Chan et al 1995，Ho et al 1993, 
Calleja-Macias 2005], with an overall mutation rate of 1.95x10"^ substitution per site 
per year in coding regions [Rector et al 2007]. This is reasonable under the current 
understanding of the HPV replication mechanism, in which the HPV virus hijacks 
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the host cell machinery and use the human DNA polymerase for its replication 
[Rattray and Strathem et al 2003]. Furthermore, the cell cycle of HPV is asexual 
without any RNA stages or any horizontal gene transfers among different clones of 
the virus. 
The identity of isolates was further confirmed to be HPV58 before inclusion to 
the analysis of the phylogeny of HPV58. The sequence of the LI gene of each isolate 
was compared with the prototype of HPV58 (GenBank accession number 
NC_001443). Surprisingly, two of the successfully sequenced isolates were 
discovered not to belong to HPV58, but HPV33, and hence were removed from the 
analysis. This alignment comparison ensured that all the sequences included in the 
phylogenetic analysis belonged to HPV58. 
Some degree of geographical distribution of variants in different gene regions 
was observed. It was commonly seen in this study that one or two variants of a gene 
dominated in the worldwide spectrum, with many other less common variants at the 
same time. These high numbers of less common variants indicated that there is a 
continuous spectrum on the genetic evolution of HPV58. 
Although a few prevalent variants of some gene regions showed a clear 
geographical preference, their effect on the overall geographical distribution was 
usually masked by the most dominant variant for that gene region. This was usually 
the most common variant that was found in many of the countries and regions 
analysed in this study. This inconsistency between HPV58 and other more 
well-studied HPV types, mainly HPV 16 and HPV 18，could be explained by several 
reasons. 
The first and the most important reason is the population mobility of the world. 
Assuming that, if HPV58 variants might have been fixed in certain geographical 
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locations, the effect may have been disturbed by the high frequency in the 
long-distance movement of people in recent centuries. These long-distance 
movements, including migration, colonisation, and slave transaction, obviously 
contribute a faster effect on the geographical distribution than the natural course of 
evolution. Since HPV is ubiquitous and commonly causes infections that last for 
months to years, the possibility that the virus is carried by the moving population to 
different part of the world is large. 
Another possible reason as suggested by Pardo et al (2005) and Bernard et al 
(2005) is that HPV types with different worldwide prevalence has a different time 
scale of evolution. They both speculated that some HPV types may replicate slower 
than HPV 16/18 and thus with a much slower evolutionary rate. The assumption that 
HPV 16 replicates faster may also explain why this type is more prevalent in the 
world, and thus for the development of these geographical signatures for HPV 16 and 
18 and to be classified more effectively. HPV58 is less prevalent than HPV 16 and 
HPV 18 worldwide, and whether geographical signatures exist is currently not 
known. 
A recent study proposed from current information on PV genomes, the 
LCR-E1-E2-L2-L1 regions are the older gene region, while E6, El, and E5 are the 
newer genes [Garcia-Vallve et al 2005]. The mutation rates of newer genes are 
generally higher than that of older genes. Our results on HPV58 generally agreed 
with this concept in that E5 and E7 had the highest average entropy per nucleotide 
among all open reading frames. However, the E6 gene, had the lowest average 
entropy value among all genes, which was found to be more conserved than 
expected. 
In every gene region of the HPV58 genome, at least one out of the five most 
113 
Chapter Five - Discussion 
prevalent variants was detected and a proportion of these major variants were found 
with a significantly higher geographical preference in Asian countries, such as the 
variants E6_WW02，E7_WW02, and E2_WW02. These variants and the nucleotide 
variations of these variants may carry the hints to disclose the epidemiologic or 
molecular link behind the higher HPV58 prevalence in precancerous cervical lesions 
and cervical cancer in Asian countries. Further epidemiological and in vitro studies 
are needed to elucidate this association. 
The phylogenetic trees constructed by the traditional maximum-likelihood 
approach and Bayesian interference concorded very well in many of the individual 
gene regions and in the artificially combined gene region. The clusters of LI, LCR, 
and the combined region estimated through these two approaches were essentially 
the same, while the statistical significance of the trees was generally higher as 
suggested by the posterior probabilities in the Bayesian trees. Only the trees of the 
E4 genes looked different between the two approaches, indicating that the 
phylogenetic trees of this gene did not concord very well and this lowered the 
confidence level of the E4 trees. 
5.2 Variability of Each Gene Region 
A total of seven out of the nine gene regions in the HPV58 genome were 
analysed under this intratype phylogenetic study, with over 400 HPV58 isolates 
collected from 15 cities/countries over the world. The El and L2 genes were not 
selected in this study since they are intratypically conserved [Chan et al 1992 (2), 
Bravo and Alonso 2007, Lee et al 2008] and their gene size is large. Therefore they 
have lower priorities for analysis in this intra-HPV58 study. 
Each gene region of these isolates was sequenced. These data provided a good 
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coverage in sequence variability for phylogenetic analysis of the HPV58 genome. 
5.2.1 E6 Open Reading Frame 
The E6 gene is not essential for the life cycle of a papillomavirus, as supported 
by at least some HPV types such as HPVlOl and 103，which do not contain E6 gene 
in their genomes [Chen et al 2007]. However, E6 codes for an oncoprotein which is 
essential for transformation of infected keratinocytes. Variations in the E6 ORF can 
lead to difference in the functions of E6 proteins, such as the affinity to cellular 
proteins, activation of telomerase and other cellular pathways, and in the stimulation 
of host immune surveillance. 
In this study, the variation of the E6 open reading frame was found to be the 
lowest among all the gene regions, as indicated by the lowest average entropy value 
per nucleotide position, 0.0043, whereas the entropy values of the other gene regions 
ranged from 0.0068 to 0.0292. In addition there were only 24 variants of the E6 gene 
detected among the 441 isolates. The number of E6 variants detected per unit length 
of gene region was also the least among all gene regions. These pieces of evidence 
indicated that the E6 gene was the most conserved gene region of HPV58 variants 
among the seven gene regions in this study. 
The most common variant, E6_WW01, had a weighed proportion of 78.2 out of 
100，which represented over two thirds of the variants collected in this study. The top 
five countries that harboured the highest prevalence of this variant showed a 
dispersed distribution with no geographical preference. However, the second and the 
fourth most prevalent variants, E6_WW02 and E6_WW04, were found to be more 
common in Asia. Twenty-four out of the 27 worldwide E6_WW02 isolates (88.9%) 
were detected in Asia. Variant E6_WW04 on the other hand was only observed in 
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Asia, representing a unique variant in this region of the world. 
The dN/dS value for E6 open reading frame was the highest among all the six 
genes investigated in our study, and was the only gene with a dN/dS ratio greater 
than one. This indicated that the selection on the E6 protein was the most likely to be 
positive, where non-synonymous mutations were more likely to bring an advantage. 
However since the dN/dS ratio was not significantly different from one, the natural 
selection of the E6 gene was still regarded as neutral. 
5.2.2 E7 Open Reading Frame 
Similar to the E6 gene, the E7 gene also codes for a protein not essential for the 
HPV life cycle but crucial for the transformation of cells [McLaughlin-Drubin and 
Miinger 2009]. Non-synonymous mutations in the E7 gene could affect its binding 
with cellular proteins, such as the pRb family. 
The variability of the E7 gene was the second highest among all ORFs as 
indicated by its average entropy per nucleotide 0.0173, whereas the average entropy 
per nucleotide of other genes ranged from 0.0043 to 0.0174. 
The most common variant, E7_WW01, had a weighed proportion of 50.3 out of 
100，meaning that this variant was found in about half of the HPV58 isolates. This 
variant was the most prevalent variant in 12 of the 15 cities/countries in this study. 
No geographical predilection was seen for this variant. The second and the fourth 
most prevalent variants, E7_WW02 and E7_WW04, were found to be more common 
in Asia, and was found in 85 out of 93 (91.4%) and 25 out of 25 (100.0%) isolates in 
Asian countries, respectively. 
The dN/dS value for the E7 open reading frame was significantly less than one, 
indicating that the selection on the E7 protein was purifying and any changes in 
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amino acid sequence were likely to cause disadvantages. 
5.2.3 E2 Open Reading Frame 
The E2 protein is essential for the transcription of HPV genes, and thus for the 
viral life cycle. Any variations in the sequence of E2 gene can result in changes in 
transcriptional activities, replication efficiency, as well as integration activities. 
The E2 protein of HPV 16 has three domains, including a transactivation domain 
at the N-terminal, a DNA-binding domain at the C-terminal, and a hinge domain 
linking between the first two domains [Gauthier et al 1991, Casas et al 1999]. Since 
the predicted secondary structure of the E2 protein of HPV58 is similar to that of 
HPV 16 (results not shown), it was reasonable to predict that the E2 protein of 
HPV58 has a similar tertiary organisation as that of HPV 16. Our data also showed 
that the DNA region coding for the predicted hinge region and DNA-binding domain 
(from nucleotide position about 3300 towards the C terminal) of the E2 protein of 
HPV58 also had the highest variability within the E2 ORF. Many of the variations in 
these two domains, including A3411G, T3587G, G3596T, G3659A, and C3764A 
were missense variations. 
The most common variant, E2_WW01, had a weighed proportion of 47.2 out of 
100, indicating that this variant was detected in about one in two HPV58 isolates. 
This variant was more commonly seen in European countries analysed in this study. 
American countries also had a higher preference for this variant; whether this 
E2_WW01 variant has a higher tendency towards the Caucasian population remains 
to be determined. The most prevalent variant, E2_WW02 was found to be more 
common in Asian countries. Sixty-six of 69 worldwide isolates (95.6%) belonged to 
this variant. All the isolates that were found for variant E2_WW03 were exclusive 
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for Asia, making this a unique variant for this region. Variant E2_WW04 seem to 
prefer non-Asian countries. 
The dN/dS value for E2 was significantly less than one. This indicated that there 
was purifying selection exerting on the E2 protein of HPV58. A mutation involving 
an amino acid change in the E2 protein was more likely to cause disadvantages. 
The average entropy per nucleotide of E2 gene was 0.0068, which was the 
second lowest among all genes. Therefore in this instance, E2 was regarded as a 
conserved gene region. It is desirable to design primers and probes for detection of 
the E2 gene since there is an approximately 350-bp very conserved region within the 
transactivation domain of the gene, from position 2950 to 3330. 
5.2.4 E4 Open Reading Frame 
The whole of the E4 gene is enclosed inside the E2 gene, but in a different ORF. 
The first position of the codon in the E4 gene corresponds to the third position in the 
E2 gene. Therefore, most positions of synonymous variation in the E2 gene became 
non-synonymous in the E4 gene, which can be regarded as a trade-off between the 
positive selection in the E4 gene and the negative selection in the E2 gene [Hughes et 
al 2005]. 
The E4 gene has been reported to be more diverse than the LCR in a previous 
study on HPV16 [Chen et al 2005]. This result was not confirmed in HPV58, whose 
LCR was found to be more diverse in terms of average entropy per nucleotide 
position. 
The most common variant, E4_WW01, had a weighed proportion of 53.5, and 
was the most prevalent variant found in all 15 cities/countries in this study. No clear 
geographical preference of this variant was observed. The second most prevalent 
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variant，E4_WW02, seemed to be more specific in Asian countries, and was found in 
74 out of 77 (96.1%) worldwide isolates with the occasional isolates from Italy 
(2.6%) and Honduras (1.3%). There seem to be tendency of E4_WW03 in Africa 
occurring in the Zimbabwean population with 34.3%，the highest out of all the 
countries that carried this strain. Variant E4_WW03, however was found to be unique 
in Asia, though this variant was not very common. 
5.2.5 E5 Open Reading Frame 
The E5 ORF encodes for a hydrophobic oncoprotein. Although the E5 protein is 
small in size, its expression level and biochemical similarities are significantly 
correlated with the oncogenicity of HPV [Bravo et al 2004, Schiffman et al 2005]. 
Non-synonymous variations in this protein can therefore result in changes in its 
transforming activity. 
There are 75 amino acids in the E5 protein of HPV58, and 15 of them showed 
non-synonymous variations. The percentage of amino acid change relative to the 
length of the protein is quite high, whether this high amino acid change will cause a 
change in the E5 protein oncogenicity remains to be determined. 
It has been reported from several studies that E5 is the least conserved gene in 
the HPV genome [Chan et al 1992 (2), Bravo et al 2004]. Our study verified this 
finding as shown by the overall entropy value for the E5 gene. Among all the ORFs, 
E5 had the highest average entropy per nucleotide positions 0.0174, whereas the 
average entropy of the other five genes ranged from 0.0043 to 0.0173. The number of 
E5 variants per unit length of gene was also the highest among all the other gene 
regions, including the LCR. However almost all the variations were synonymous, 
resulting in a low dN/dS value for the E5 ORF. The dN/dS value for the E5 gene was 
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the second lowest among all genes, indicating that a purifying selection on the E5 
protein was high. A change in the amino-acid sequence on the E5 protein was more 
likely to cause disadvantages. 
The most common variant, E5_WW01, had a weighed proportion of 52.2, 
indicating a worldwide domination since it accounted for about half of the HPV58 
isolates. It was the most prevalent variant in 11 out of the 15 cities/countries in this 
study. The second most common variant, E5_WW02, was more frequently detected 
in Asian and American countries. It was the most or the second most commonly 
detected variant in all the six Asian cities/countries and in three out of the six 
American countries in this study. The third most prevalent variant E5_WW03 was 
more common in non-Asian countries, especially in Africa. 
5.2.6 LI Open Reading Frame 
The LI ORF of HPV has widely been accepted to be the most conserved region 
within the genome at protein level and antigenicity [Ho et al 1993，de Villiers et al 
2004]. Surprisingly our results have shown that the average nucleotide entropy for 
the LI gene was only the third most conserved gene among the six genes under 
investigation. The DNA sequence of the LI gene was more variable than that of the 
E6 and the E2 gene in terms of average entropy. 
Non-synonymous variations in the LI gene may have the potential to cause 
differences in the conformation of the LI protein, and hence the viral particles. This 
change may influence the epitopes for immune recognition which may lead to 
differences in an immune response. 
The distribution of the LI variants was found to be more even than of other 
genes. No major variant was found to reside in a particular country or region. Variant 
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L1_WW001, with a weighed proportion of 33.2 out of 100，the lowest among the 
most common variants in all ORFs, was the most prevalent LI variant worldwide. It 
was the most common variant in 11 out of the 15 cities/countries in this study. This 
variant seems to occur more commonly with a slightly higher prevalence in the 
non-Asian countries, with Brazil occupying the first place with this variant detected 
in all their isolates, followed by Great Britain, Mexico, Canada, and Italy. The second 
most prevalent variant, L1_WW002 appeared to be more common in Asia, where 41 
out of 47 (87.2%) of this variant were detected in Asian isolates. The LI proteins 
encoded for by these two variants had only one residue difference in their amino acid 
sequence. The fifth amino acid of L1_WW001 was leucine while that of L1_WW002 
was phenylalanine. Further studies need to be carried out to determine the 
implication of these two variants as to which one, or both, is a more ideal candidate 
to be included in the future second generation of HPV prophylactic vaccine. 
The dN/dS value for the LI open reading frame was the lowest among all the 
six genes in this study and was significantly less than one. This indicated that the 
selection exerting on the LI protein was most likely to be negative among all genes 
and that non-synonymous mutations in the LI gene were most likely to bring a 
disadvantage to the life cycle of HPV58 than those of other genes. 
5.2.7 Long Control Region 
Our data on the LCR was consistent with all the previous findings in that the 
LCR was the most variable region in the genome [Stewart et al 1996, Calleja-Macies 
et al 2005, Prado et al 2005]. The average nucleotide entropy of the LCR, found to be 
0.0292, was the highest among all gene regions, with more than 2.5-fold higher than 
that of the LI ORE 
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The genomic diversity of the LCR was found to be less than 5% among all the 
analysed HPV58 isolates, which agreed with previous findings in other HPV types 
[Calleja-Macies et al 2005, Stewart et al 1996]. 
Insertions and deletions were much more common in the LCR than in the other 
gene regions. There were 11 locations of indels, which lengths ranged 1-43 bp. 
Insertions have also been reported in LCR in variants of other HPV types [Ho et al 
1993, Heinzel et al 1995]. In some studies, variants with indels are excluded from the 
phylogenetic analyses due to their low frequencies of observation. In our study, all 
the LCR variants with indels were taken into account. This may provide a more 
complete picture for the pattern of evolution. 
The distribution of variants was evenly dispersed for the LCR region owing to 
the relatively higher variability of the region. There were two most common variants, 
LCR_WW001 and LCR_WW002 circulating among the LCR variants in his study. 
The weighed proportion for LCR—WWOOl was 22.1 and for LCR—WW002 was 22.0, 
both of which were much lower than that of the top variant in other gene regions. 
The distribution of the LCR—WWOOl variant was diverse in all 15 cities/countries 
and no geographical preference was seen with this variant in any countries. The other 
most prevalent variant, LCR_WW002, showed a slightly higher prevalence in 
non-Asian countries than in Asian countries, 67.8% versus 32.2%. On the contrary, 
LCR_WW003 tends to be more prevalent in Asia, though the numbers were not very 
high. Variant LCR_WW006 also seemed specific only to Zimbabwe and USA. It 
would be worthwhile to investigate this association. 
5.3 Phylogenetics of HPV58 
5.3.1 Natural Selection Pressure 
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In this study, the average non-synonymous to synonymous substitution rate ratio 
approach was used to determine the selection pressure exerted on each gene. Five out 
of six HPV genes investigated in the current study had dN/dS ratios significantly less 
than one, ranging from 0.18 to 0.67. This indicated that HPV58 was recently under a 
strong purifying selection pressure, which is consistent with recent studies [Rector et 
al 2007, Chen et al 2005]. 
The E2 and E5 gene are the two ORFs reported to have a positive selection 
pressure as observed in HVP16, while all the other genes have a negative selection 
pressure [Chen et al 2005]. Our results on HPV58 did not align with this study on 
HPV 16. The E6 gene of HPV58 was the only gene which had a dN/dS value greater 
than one, although not statistically significant; it was the only one gene which is 
possibly under a recent positive selection pressure. All dN/dS values of other genes 
were significantly less than one, which indicated that these genes were under a 
negative or a purifying selection recently. 
The difference between the dN/dS values of the E6 gene of HPV 16 and HPV58 
might be an explanation in the difference in oncogenicity of the two HPV types. The 
E6 gene is highly expressed in the late stages of cancer development. When 
compared with the infection of HPV 16, a larger proportion of high-grade lesions 
caused by HPV58 seem to stop progressing to cancer as reflected by the sharp 
decrease in the prevalence of HPV58, but not in HPV 16, from high-grade squamous 
intraepithelial lesion (HGSIL) to carcinoma [Lai et al 2006, Castellsague 2007]. 
Since the E6 protein is a major target of immune recognition for clearance of infected 
cells in these pathological stages [Roden et al 2004, Sin 2006], the need for amino 
acid changes in the E6 protein may be higher to alter the epitopes of the protein of an 
HPV type which is recognized for viral clearance so as to evade the host immune 
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response. 
5.3.2 HPV58 Lineage Using the LI Gene 
Data from this study has shown that the LI gene was identified to be the best 
gene region for HPV58 lineage definition for several reasons. Firstly, the LI gene, 
containing 1,575 bps, is long and informative for phylogenetic analysis. The ML 
phylogenetic tree that was obtained from these isolates contained the highest number 
of statistically significant nodes and hence was the most reliable among all the ORFs. 
Secondly, although the phylogenetic trees of the LCR contained five clusters, the 
four LI clusters were comparatively more statistically significantly defined. The 
evolutionary distances among the LI clusters were longer and more comparable, and 
the overall clustering pattern of the LI variants was far more similar to that of the 
variants of the joint sequence E6-E7-E2-E5-L1 -LCR. Thirdly, many of currently 
available detection methods for HPV types are based on the LI gene. Developing a 
lineage system based on the LI region facilitates possible applications for diagnostic 
or medical use. Fourthly, the LI gene is the most conserved gene region among the 
different types of papillomaviruses [de Villiers et al 2004]. Any classification system 
built on the LI ORF are also the most stable. 
A total of four clusters were clearly observed in the phylogenetic trees, as 
shown in figures 4.12(a) and 4.12(b). In the Bayesian tree, the four clusters were 
separated significantly by branches with lengths from 0.11 to 0.15 substitution per 
nucleotide position, which are approximately equal to 4.7 to 7.9 million years. It is 
reasonable to see few intermediate variants located between two clusters in the 
phylogenetic trees, since evolution is a continuous process. 
124 
Chapter Five - Discussion 
5.3.3 Methods for Lineage Identification 
A classification system separating the LI sequences into each one of the lineage 
was made possible. Along a 1250-bp segment of the LI gene (nucleotide 5579-6828), 
a total of 12 representative nucleotide changes were observed (Table 4.7). Eight of 
these represented unique markers for each cluster. Identification of these eight 
nucleotide changes will enable the separation of LI variants into each cluster. 
There were also sets of combined markers identified in the sequence to facilitate 
cluster identification. The set involving the least number of nucleotide changes 
consisted of only two positions 6014 and 6827. Under this scheme, the identification 
of 6014C and 6827C of a LI variant identifies this LI variant to be identified as 
cluster A, 6014A and 6827C into cluster B, 6014C and 6827 A into cluster C, and 
6014A and 6827A into cluster D. 
Another set of combined markers involved five positions separated by 188 bps, 
which was the shortest distance among all identified marker sets. Nucleotide 
positions of 6641, 6798，6822，6827 and 6828 were the five positions responsible for 
the cluster identification. A LI variant with A-A-G-C-A at these five positions 
identifies this variant to fall into cluster A, G-A-G-C-A into cluster B, G-A-G-A-A 
into cluster C, and G-G-A-A-G into cluster D. Since the five markers were located 
within a segment of 188 bps, only a single sequencing reaction is needed for the 
identification of these clusters by this method. 
The identification of only two or three nucleotide positions can be made with 
ease using for example single nucleotide polymorphism (SNP) detection techniques 
or DNA hybridisation techniques. This identification system is easy, quick, and 
simple to interpret. Moreover, further work can be done to elucidate if there are any 
disease risk associations related to these four clusters. 
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Besides sequencing techniques, RFLP can be an alternative approach to identify 
the clusters of HPV58. A possible combination of primers for PGR and 
endonucleases for restriction of PGR products was suggested, by which different 
patterns are created for different HPV58 LI clusters. This method does not require 
sequencing of DNA and can be more economical. 
5.3.4 Geographical Distribution of the Four Lineages 
The LI cluster A (53.7%) was the most frequently detected cluster of HPV58 in 
the world, followed by cluster C (21.3%), cluster D (13.8%) and cluster B (11.1%). 
More than half of the European and American population harboured cluster A, it 
seemed like this cluster was less prevalent in the Asian and the African populations. 
When cluster A was analysed in terms of its distribution by continents, Europe came 
top with 88.2%, followed by America (72.6%), Africa (47.87%) and Asia (37.2%). 
Here, there seem to be a geographical preference, it would be interesting to collect 
more samples from these cities/countries to verify this finding. 
Although the LI cluster B was the least prevalent cluster worldwide, it was 
more commonly detected in Asia. The prevalence of this cluster in Asia was at least 
six times as high as that in the other continents, making it an Asia-specific lineage. 
Further work is warranted to confirm this finding. 
Similar to cluster B, cluster C was also found to be an Asia-associated lineage. 
Furthermore, it was interesting that none of the African isolates belong to this lineage. 
The contrasts between Asian and African populations may be a main reason behind 
the difference of the prevalence. 
Cluster D was more commonly found in the African isolates. Since the common 
ancestor of human beings is believed to come from Africa, this lineage could also be 
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the ancestor of the other lineages. The root of the phylogenetic tree might point to 
this cluster. Another evidence for this hypothesis was that a higher frequency of 
detection was observed in America (15.6%), especially South America (24.4%), than 
in Europe (5.9%) and Asia (3.7%). This might be explained by the population 
movement from Africa to South America due to the large-scale slave trade starting 
from the 16 '^' century. Nonetheless, this prevalent LI cluster more observable in 
Africa deserves further attention to verify its implication in this population. 
Overall, the tendency of geographical predilection of the four clusters seem to 
be cluster A for Europe, both cluster B and C for Asia, and cluster D for Africa. 
Further work needs to be done to elucidate any associations. It would be worthwhile 
to carry out disease risk association analyses with these cluster information as this 
will shed more light on why this HPV type is more prevalent in Asia than in any 
other parts of the world. 
In addition to risk association studies, it would be interesting to see if the 
nucleotide changes specific to each cluster confer any immune escape so as to 
explain why a certain variant or cluster is more predominant in a population. 
5.3.5 Recombination 
The presence of recombination is another topic for the phylogenetic study of 
HPV and is drawing increasing attention to researchers. Since most HPV-inducing 
diseases are believed to have a monoclonal origin of HPV infection, in vivo evidence 
of HPV recombination is theoretically rare. However, some bioinformatic evidence 
has been put forward to support that recombination did occur at some stage of 
papillomavirus evolution [Bravo and Alonso 2007, Narechania et al 2005, Varsani et 
al 2006], where the L2 gene was proposed to contain the highest number of probable 
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recombination sites [Narechania et al 2005, Varsani et al 2006]. Until now, all the 
recombination analyses on papillomavirus were made on a wide range of 
papillomavirus types, and no such analysis has been made on a single papillomavirus 
type. This study provides a good database to further study the intra-type 
recombination of HPV via a bioinformatic approach. 
5.4 Evaluation of Commonly Used Primers 
The effectiveness to amplify the HPV58 genome using five common primer 
systems, namely PGMY09/11, MY09/11, GP5+/6+, SPF, and LIF/LIR, targeting the 
LI gene region of HPV was predicted by matching the sequences of the primers with 
the HPV58 sequence data generated in this study to reveal the mismatched positions. 
The purpose of this alignment was to predict which set of these primers were the 
most effective in terms of complementarity match with the LI variants that were 
determined in this study, and to give an overview of how efficient these common 
primers are in the detection of HPV with particular emphasis on the detection of 
HPV58. It was predicted that the PGMY09/11 and MY09/11 primer systems were 
more desirable in detection of HPV58 since they contained the least number of 
mismatches. The number of mismatches increased from the SPF to GP5+/6+ primers, 
where it was found that GP5+/6+ carried the highest number of mismatches. 
The presence of these mismatches in the commonly used primer systems could 
lead to false negative results in the detection of certain HPV58 variants. This may 
result in the underestimation of HPV58 prevalence in some regions of the world, and 
hence the need for a vaccine against HPV58 in these regions. Some HPV58 single 
infection cases may be wrongly reported as HPV-negative, while some HPV58 
co-infections may be reported as non-HPV58 infections, due to the failure in the 
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detection of HPV58. These effects could even be more significant in certain 
populations that harbour a larger proportion of the less sensitive HPV58 variant. 
5.5 Limitations of the Current Study 
A total of 571 specimens were collected from various regions in the world. All 
of them were previously detected to be HPV58 positive by our collaborators. 
However, only 441 of them were successfully amplified by our own E6/E7 
type-specific primers by double-round PGR. The failure of the rest to be amplified 
was suspected to be due to the drop in sample quality during transportation. One of 
the collaborators has sent two sets of specimens from Europe to Hong Kong. The 
first set of extracted DNA was stored in water in room temperature during the 
shipment and almost all of the DNA failed to amplify. The second set was 
precipitated and stored in ethanol and kept in ice bags during transportation and the 
success rate increased to about 80%. This demonstrated that the degradation of DNA 
during the transportation can be a significant factor for the failure to amplify HPV 
DNA. 
Another possible reason for the failure in obtaining the sequence from HPV58 
positive specimens is that certain regions, such as LI-3,，were technically more 
difficult to amplify by PGR due to the limited region for designing effective primers. 
The region available was sub-optimal for primer design and thus the LI-3，PGR was 
not very sensitive. Suitable primers targeting a longer DNA segment flanking these 
gene regions can be a solution, provided that the quality of DNA is good enough for 
the amplification. In addition, rolling circle amplification can be used enhance the 
quality of the circular HPV DNA for further PGR and sequencing. 
In this study, cycle sequencing was performed, which has limitations in the 
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detection of minor variants that may be present in each sample. If a sample contains 
a mixture of HPV58 variants, PGR amplifies the major variant in the sample more 
effectively. The variant(s) having a smaller proportion in the sample are less likely to 
be amplified. Therefore our results can only reflect the major variants in each sample. 
Mixture of variants of HPV16 was also reported in the past [Ho et al 1991], but the 
sources of the different variants were not confirmed. In addition, the Taq DNA 
polymerase used in PGR has an error rate of about 10'^  per base pair and may lead to 
a certain extent of error during amplification. 
The second limitation in this was that we only had information on the 
geographical location and the ethnic background of our patients was not completely 
clear, which may have made the interpretation of our data a little obscure. However, 
we believe that this study will give a starting point for information to future analyses 
for HPV58 lineage studies. 
Another limitation of this study was that there was a lack of information on the 
functionality of the different viral proteins of HPV58. Unlike for HPV16，where 
many of the viral proteins are well studied and defined in in vitro experiments in 
their biological and physical properties, very few studies have been done in the past 
focusing on viral proteins of HPV58. Thus any prediction on the implications of the 
different genomic variations needs further investigation. 
5.6 Future Studies 
To further process the specimens that failed to be amplified in this study, the 
following approaches can be considered. For those isolates showing positive results 
in the screening PGR targeting the E6/E7 region while negative in the sequencing of 
other genes, new sets of primers targeting a shorter DNA fragment can be designed 
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for the amplification of the failed gene regions. For those showing negative results in 
the E6/E7 PGR, a screening by PGMY09/11 primers can be done to confirm the 
presence and the quality of HPV58 DNA. This may answer the question if the 
integrity of the length of the DNA is the culprit for the failed E6/E7 screening PGR. 
For the negative samples, rolling circle amplification can be used to amplify the 
circular HPV DNA before further trials on PGR and sequencing. With the 
incorporation of these procedures, some of the negative samples in this study may 
become positive so as to increase the positive rate and to reduce any bias in positivity 
of the samples for HPV58. 
A similar phylogenetic study can be carried out using the amino acid sequence 
approach rather than the DNA sequence approach as in this study. Focusing on the 
amino acid sequence may be more meaningful in the clinical sense, by omitting the 
effect of the silent mutations on sequence alignments. 
The most prevalent variants in each gene region may represent the most well 
adapted protein and hence can act as the template sequence of the HPV58 viral 
proteins for the design of in vitro studies on the HPV viral proteins. The in vitro 
studies may perhaps provide some answers or clues to the reasons behind why some 
strains of the viral proteins dominate in the world, and how the structure of the 
proteins or their expression levels can affect the function of the HPV proteins. 
In this study, some variants are more commonly detected in Asia. In vitro 
experiments can be carried out to determine if there are differences in mechanisms of 
protein control between these variants and other variants more prevalent in other 
parts of the world. 
The risk associations between the HPV58 lineages and pathology and 
oncogenicity of the virus, ethical or geographical distribution, or host factors can 
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only be answered by epidemiological studies on HPV58. The lineages of HPV58 can 
be determined according to the suggested methods proposed in this study and results 
correlated to host genetics. 
Similar studies on other HPV types of the same HPV species, such as HPV16, 
HPV33, and HPV52, can be performed. Through comparison, a broader picture with 
intertype spectrum can be drawn from the sequence data generated from different 
HPV types. Hopefully a better elucidation on the viral evolution of these high-risk 
species can also be made through this comparison. 
L1_WW001 and L1_WW002 were two of the most common variants found in 
the LI gene that may carry a higher clinical significance in term of vaccine 
development. Since only one or a very few LI strains can be included in a 
prophylactic vaccine, further studies are required to investigate the effectiveness of 
including which of the two variants in the future development of the new generation 
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